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Summary
The work presented in this thesis is on the characterisation of the single stranded DNA 
(ssDNA) binding protein of the human herpesvirus, Kaposi’s sarcoma herpesvirus (KSHV), 
encoded by the ORF6 gene. There is a core set of six proteins conserved throughout the 
herpesvirus family that are required for viral DNA replication and are active at the 
replication fork. These proteins function as a DNA polymerase and its processivity factor, a 
trimeric helicase-primase complex and a single-stranded DNA binding protein. In KSHV 
these functions are carried out by the proteins expressed by the following genes: ORF9 
(DNA polymerase), ORF59 (processivity factor), ORF56 (helicase), ORF44 (primase), 
ORF40/41 (helicase-primase associated factor) and ORF6 (single-stranded DNA binding 
protein). Current models of herpesvirus DNA synthesis are based mostly upon knowledge 
of the herpes simplex virus type 1 (HSV-1) replication fork proteins, which have been more 
extensively studied than any of their homologues in other herpesviruses. The DNA 
replication proteins in KSHV have not been well studied and therefore their roles in KSHV 
DNA synthesis have been largely predicted by analogy with their HSV-1 counterparts.
To date there has been no published characterisation of the KSHV ssDNA binding protein 
(pORF6). The work completed for this thesis describes the over-expression and purification 
of pORF6 and characterisation of its binding to ssDNA.
A recombinant baculovirus expressing pORF6 was constructed and used to infect 
Spodoptera frugiperda cells. The protein was purified from these cells using heparin 
sulphate and mono-Q columns. Following successful purification of pORF6 it was
established that it could bind to ssDNA, using an electrophoretic mobility shift assay 
(EMSA) and surface plasmon resonance measurements on a BIAcore instrument. The 
number of nucleotides required for pORF6 to bind to ssDNA and the effect of NaCl on 
binding were also investigated, revealing that optimal binding occurred at 150 mM NaCl. 
Fourteen nucleotides were required for pORF6 to bind, however, binding became more 
efficient as the length was increased to twenty.
ICP8, the HSV-1 homologue of pORF6 has been shown to bind to ssDNA in a cooperative 
manner. The binding mechanism of pORF6 to a ssDNA of thirty-two nucleotides was 
investigated, again using an EMSA and surface plasmon resonance. This revealed that 
pORF6 may also bind to single-stranded DNA cooperatively. A comparison of ICP8 and 
pORF6 binding to ssDNA using the BIAcore indicated that they bind to single-stranded 
DNA with a similar affinity.
A panel of monoclonal antibodies was generated against pORF6 and was tested by western 
blotting, immune-fluorescence and immune-precipitation, using Spodoptera frugiperda cells 
infected with a recombinant baculovirus expressing pORF6. Human B-cells infected with 
KSHV that had been induced into their lytic cycle were also used in immune-fluorescence 
assays, which revealed pORF6 to be present in globular areas within the cell, reminiscent of 
herpesvirus DNA replication compartments.
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Chapter 1 
Introduction
1.1 Introduction
The work presented in this thesis is on the characterisation of the ssDNA binding protein 
of the human herpesvirus, Kaposi’s sarcoma-associated herpesvirus (KSHV), encoded by 
the ORF6 gene. The introduction will begin with a discussion of some of the general 
properties of the herpesvirus family. More detailed descriptions of herpesvirus DNA 
replication and other ssDNA binding proteins will follow.
1.2 The Herpesviruses
1.2.1 Herpesvirus characteristics
The herpesviruses are a large and diverse family of over 100 viruses that have been 
identified in mammals, birds, fish, amphibians and reptiles. They share a variety of 
common characteristics, including their genome type, virion morphology, basic mode of 
replication and the ability to establish latent infection in their natural hosts. The 
herpesvirus-common characteristics have been summarised by Roizman et al. (1992) and 
Davison & Clements (1998).
Herpesviruses possess large, linear double-stranded DNA genomes and hence have the 
capacity to encode many viral proteins and enzymes. The length of DNA ranges from 
approximately 120 to 250 kbp. Herpesvirus virions are large and complex with a 
common morphology consisting of four elements: core, capsid, tegument and envelope 
(Dargan, 1986) (figure 1.1). The core consists of the dsDNA genome, which is packaged 
into an icosahedral capsid (Widly et al., 1960; Furlong et al., 1972). The nucleocapsid is 
surrounded by an amorphous layer known as the tegument (Roizman and Furlong, 1974). 
The tegument is enclosed within an envelope consisting of a lipid bilayer, derived from 
golgi membranes, which contains viral glycoproteins (Spear and Roizman, 1972). The 
number of different viral glycoproteins on the virus particle varies between different
Envelope
glycoproteins
Tegument
DNA core
Viral
envelope
Icosahedral
Capsid
Figure 1.1 Generalised structure of a Herpesvirus virion
A schematic representation o f a herpesvirus particle virion is shown, with 
the DNA core, icosahedral capsid, tegument layer and lipid envelope 
indicated. The viral envelope also contains various glycoproteins which 
protrude from the surface. The number o f envelope glycoproteins varies 
amongst the herpesviruses.
herpesviruses.
Herpesviruses encode a variety of enzymes involved in nucleotide metabolism 
(thymidine kinase, thymidylate synthase, dUTPase, ribonucleotide reductase), which 
enable them to replicate in resting cells (Kit and Dubs, 1965; Pyles et al., 1992; Bacetti et 
al., 1986; Brown et al., 1995). They also produce viral enzymes involved in DNA 
synthesis (e.g. DNA polymerase, DNA helicase, primase).
Herpesviruses are able to alter the cellular environment to suit their needs. These 
alterations include shutting off or stimulating host cell molecular synthesis, inhibiting or 
inducing host cell replication, or immortalizing the host cell. Although many 
herpesviruses encode genes that can transform cells in experimental systems, in only a 
few cases is it a part of the in vivo life cycle, e.g. the immortalization of B cells by 
Epstein Barr Virus (EBV) in the process of establishing latency (Miller et a l , 1982).
The lytic life cycles of the herpesviruses are similar. Virus entry to the host cell is 
through glycoprotein-mediated binding and fusion with the cell membrane (Sears et a l , 
1991; Spear, 1993). The nucleocapsid complex is then transported to the nuclear pore, 
where the viral genome is released into the nucleus (Sodiek et a l , 1997). Replication of 
the viral genome and assembly of progeny nucleocapsids takes place in the nucleus 
(Furlong et al, 1972). After encapsidation of the genomic DNA, the nucleocapsids are 
released from the nucleus by budding through the inner nuclear membrane (Vlazny et a l , 
1982; Vernon et a l , 1981). It is thought that virions acquire their final envelope from 
post-endoplasmic reticulum cytoplasmic compartments (Skepper et a l, 2001). Mature 
virions are thought to exit the cell by a process of exocytosis. Ultimately, production of 
infectious progeny virus is usually accompanied by destruction of the infected cell. DNA
replication is mediated largely by viral enzymes but is dependent on host cell enzymes 
for several functions.
Herpesvirus genome arrangements consist of various combinations of unique sequences 
and repeated elements. These repeated elements may be present either internally or at the 
genome termini. This gives rise to a variety of distinct genome organisations and sizes 
depending on the sequence arrangements and the copy number of the repeated regions, 
respectively. Hence, herpesvirus genomes have been classified into seven groups 
according to genome arrangement, as described by Roizman et al.(1992) and Davison & 
McGeoch (1995). The structures of the seven genome classes are represented in Figure 
1.2 .
Group 0 genomes have a single unique coding region with no repeat units (e.g. tree 
shrew herpesvirus). Group 1 genomes have single direct repeats at each terminus (e.g. 
human herpes virus 6). The genomes of group 2 have multiple repeats at each terminus 
(e.g. KSHV). Group 3 genomes also have multiple repeats at each terminus but 
additionally have internal copies of these repeats in the opposite orientation, resulting in 
a genome with two unique regions (e.g. cottontail rabbit herpesvirus). Group 4 genomes 
consist of two unique regions separated by a group of internal repeats. Like groups 2 and 
3, each end of the genome is also flanked by groups of direct terminal repeats but these 
are unrelated to the internal repeats (e.g. EBV). The genomes of group 5 have two 
unique regions, each region being flanked by a pair of unrelated inverted repeats, but 
those flanking the U l are very short (Varicella-zoster virus). Group 6 genomes are 
related to the group 5 genomes but have much longer repeats flanking the U l region. 
They also contain a sequence repeats that are found in the same orientation at each 
terminus and in inverted orientation between the internal repeats flanking U l and Us (e.g.
0►►► ►►►
►►► UL < « US ►►►
►►► UL ►►►
US ►►►
Q -
t r l
UL US <■
IRl IRs TRS
UL
US
TRi IRl IRs TRS
Figure 1.2 Herpesvirus genome structures
A schematic representation o f the various genome structures o f the herpesviruses. Unique 
regions are represented as single lines. Repeat regions are shown as boxes with their relative 
orientation indicated by an arrow (Roizman et al., 1992; Davison and McGeoch, 1985). The a 
sequence o f  the group 6 viruses contains the minimal packaging and cleavage sequences.
herpes simplex virus-1).
The presence of long inverted repeats flanking Us in the group 5 genomes results in the 
Us region being able to invert through recombination. This results in the group 5 
genomes existing as a mixed population of two isomers. The increased size of the U l 
repeats in in group 6 genomes means that both the U l and the Us regions can invert at 
high frequency resulting in four genomic isomers (Hayward et a l, 1975).
A distinctive feature of the herpesviruses is their ability to establish latent infections in 
their natural hosts, an effective mechanism of evading the host immune system. 
Following primary infection, viral DNA takes the form of a closed circular molecule, 
which is present at low copy number. Few, if  any viral proteins are expressed. In 
dividing cells, the viral DNA is replicated via specific viral origins and cellular 
replication proteins, and is then segregated into the daughter cells (Yates et a l , 1984; 
Yates et al., 1985; Hu et a l, 2002). Such latent infections typically last for the entire life 
of the host. The cell type in which latency is established varies between the different 
herpesviruses e.g. latent HSV-1 is found in neurons of dorsal root ganglia whereas latent 
EBV is primarily found in B lymphocytes. Reactivation to productive infections may 
occur sporadically throughout the life span of the host.
1.2.2 Herpesvirus classification
The mammalian and avian herpesviruses comprise three subfamilies (Roizman et al., 
1981). Classification has traditionally been made on the basis of differing biological 
properties, such as host range, length of reproductive cycle, cytopathology and site of 
latent infection. However, increasingly genome sequence data are being used for the 
purpose of herpesvirus phylogeny (e.g. McGeoch et al., 1995). In most cases, the 
original classifications have been substantiated by the groupings, which have now been 
made on the basis of comparison of sequence data. The updated herpesvirus 
classifications were published in the current International Committee on Taxonomy of 
Viruses report (Minson et al., 2000). The herpesvirus sub-families are as follows:
Alphaherpesvirinae
These are typically neurotropic viruses with a short reproductive cycle. They spread 
rapidly in culture and have a wide host range in vitro. They are highly cytolytic and 
some members have been shown to establish latent infections in sensory ganglia. This 
subfamily contains the genera Simplexvirus, Varicellovirus, “Marek’s disease like virus” 
and “Infectious laryngotracheitis-like virus”
Betaherpesvirinae
The reproductive cycle of these viruses is long and the infection progresses slowly in 
culture. Infected cells often become enlarged and fuse to form multinucleate cells called 
cytomegalia. Another characteristic is a restricted host range. Latent infections have 
been associated with cells of the monocyte series. This subfamily contains the genera 
Cytomegalovirus, Muromegalovirus and Roseolovirus.
Gammaherpesvirinae
Gammaherpesviruses are generally lymphotropic and often establish latency in T or B 
lymphocytes. Host range in cell culture and length of reproductive cycle is variable, as is 
the resulting cytopathology. Productive infections are associated with the development 
of lymphoproliferative disorders. Some members also cause lytic infection in epithelioid 
and fibroblastic cells. The subfamily contains two genera: Lymphocryptovirus and 
Rhadinovirus.
1.2.3 Human herpesviruses
Human herpesviruses are generally ubiquitous, with large proportions of the world-wide 
population having been exposed to and latently infected by one or more of these viruses. 
They are usually spread by close contact via bodily secretions. Eight herpesviruses that 
infect humans have been identified to date. Generally, primary herpesvirus infection in 
immunocompetent hosts does not result in severe or fatal disease. However, herpesvirus 
infections in certain susceptible populations, such as immunocompromised individuals, 
may cause serious illness.
Three alphaherpesviruses are known to infect humans. Herpes simplex viruses 1 and 2 
(genus Simplexvirus) are closely related. Both are associated with mucosal infections 
and establish latency in sensory ganglia. HSV-1 is primarily associated with mucosal 
infections of the mouth and throat and may cause symptoms including fever and more 
commonly, oral lesions (cold sores), but is also associated to a lesser extent with genital 
mucosal infections. Conversely, HSV-2 is primarily associated with mucosal infections 
of the genitalia and to a lesser extent the mouth and throat. Both viruses can reactivate,
which is manifested by lesions in the skin. Varicella-zoster virus (genus Varicellovirus) 
is the third human alphaherpesvirus and the causative agent of chicken pox during 
primary infection. VZV establishes latency in sensory neurones and reactivation results 
in shingles.
Human cytomegalovirus (genus Cytomegalovirus) is a betaherpesvirus that causes 
widespread infection in humans. As with other human herpesviruses, primary infection 
is usually asymptomatic but severe disease can occur in susceptible individuals infected 
with HCMV. Human herpesvirus-6 and human herpesvirus-7 (genus Roseolovirus) are 
more recently identified human betaherpesviruses. Both are associated with febrile 
illnesses in children and post-transplant disease in immunosuppressed transplant 
recipients. Human herpesvirus-6 has been found in a latent state in macrophages (Levy, 
1997) whereas the site of latency for human herpesvirus-7 is unclear.
The final two human herpesviruses are members of the Gammaherpesvirinae. EBV 
(genus Lymphocryptovirus) was the first human gammaherpesvirus to be identified and is 
the causative agent of infectious mononucleosis. EBV establishes latency in B- 
lymphocytes and has been associated with malignancies including Burkitt’s lymphoma, 
Hodgkin’s disease and nasopharyngeal carcinoma. Human herpesvirus-8 (genus 
Rhadinovirus), also known as Kaposi’s sarcoma-associated herpesvirus (KSHV), is the 
most recently identified human herpesvirus. It is the causative agent of Kaposi’s 
sarcoma (KS) and is also associated with two other human cancers, primary effusion 
lymphoma (PEL) and multicentric Castleman’s disease (MCD).
1.3 KSHV
1.3.1 Discovery and epidemiology of KSHV
KSHV was first identified from an AIDS-KS skin lesion in 1994 using representational 
difference analysis (Chang et a l, 1994). Within two years of its discovery the KSHV 
genome was sequenced from a PEL-derived cell line and from a KS lesion (Russo et a l, 
1996; Neipel et a l, 1997).
Unlike most human herpesviruses, KSHV is not ubiquitous but is distributed according 
to a combination of geographic and behavioural risk factors. In northern Europe and 
northern America less than 10% of the population have been infected with KSHV 
(Iscovich et a l, 2000). The rates of infection in Mediterranean countries are higher and, 
within Europe, KS occurs most frequently in elderly males of Mediterranean ethnicity 
(Simpson et a l, 1996). In some areas of Africa, adult populations have infection rates of 
over 50% (Gao et a l, 1996).
KSHV seroprevalence in high-risk populations is much greater than in the general 
population. Homosexual men can have asymptomatic infection rates approaching 40% 
and KS is more frequent among HIV negative homosexual men than the general male 
population (Gao et a l, 1996; Martin et a l,  1998, Blackboum et a l,  1999). In many 
developed countries women are much less likely to be infected than men (Keddes et a l, 
1997). Epidemiologic studies show that only a small percentage of healthy adults who 
are infected with KSHV will develop symptomatic disease. Symptomatic disease 
primarily occurs among individuals with immune suppression e.g HIV positive 
individuals, chemotherapy and transplant patients, and the elderly.
1.3.2 KSHV disease manifestations
Three diseases have been associated with KSHV infection so far. Kaposi’s Sarcoma is a 
vascular tumour composed of proliferating spindle cells, thought to be derived from an 
endothelial lineage. PEL is a B-cell lymphoma, which occurs as malignant effusions in 
visceral cavities, although malignant cells can be found in adjacent visceral organs and in 
the peripheral circulation. MCD is a reactive lymphadenopathy, involving enlargement 
of lymph nodes.
1.3.3 Types of KS
Four clinical categories of KS have been described. These are classical KS (found 
predominantly in the Mediterranean), endemic KS, epidemic KS (AIDS-KS) and 
immuno-suppression associated KS. Endemic KS in sub-Saharan Africa is responsible 
for up to 12% of all malignancies and has the worst disease prognosis of all the KS types 
(Armes, 1989). KS in childhood is virtually nonexistent in North America or Europe but 
it occurs in endemic areas of Africa. Childhood KS is aggressive and rapidly fatal. 
Immuno-suppression KS is often associated with transplant patients with 1 in 500 
patients developing the disease.
1.3.4 KSHV transmission
KSHV is mainly spread through sexual contact, with gay and bisexual men being most 
susceptible to infection in the developed world (Martin et a l , 1998, Blackboum et a l , 
1999). In Africa KSHV is spread via casual contact between children and young adults.
The exact means of transmission is not known but it may be associated with oral contact 
(Pauk et al., 2000).
1.3.5 Treatment of KSHV
As herpesvirus DNA replication is largely autonomous from the host cell replicative 
machinery, this stage of the life cycle is a suitable target for antivirals. Herpesvirus DNA 
replication enzymes are sufficiently distinct from the cellular replication enzymes to 
allow specific targeting of viral functions. The majority of anti-herpetic drugs are 
nucleoside analogues.
Some of the drugs that were developed to treat other herpesvirus infections (HSV-1 and 
HCMV) successfully prevent KS, but it is not clear whether they treat existing tumours 
(Kedes and Ganem, 1997). KSHV is sensitive to both gancyclovir and cidofovir, but is 
insensitive to acyclovir. Treatment of the underlying immune deficiency appears to be 
the best current approach for controlling KSHV associated diseases. In cases of AIDS- 
KS, treatment with an effective antiretroviral therapy can cause KS tumours to regress. 
When individuals receiving chemotherapy have their medication withdrawn, tumour 
regression is also observed.
1.4 KSHV molecular biology
1.4.1 Genome structure
KSHV is the only human member of the Rhadinovirus genus discovered to date (Moore 
et al., 1996). It was first sequenced using cosmid and phage genomic libraries from the 
BC-1 cell line and 81 ORFs were identified (Russo et al., 1996). Other genes were
subsequently discovered by Neipel et al. (1997) and Sarid et al. (1998). The structure of 
KSHV is similar to herpesvirus saimiri (HVS) as it has a long unique region (LUR) 
flanked by terminal repeats (TR). The long unique region of the KSHV genome is about 
145 kb in length and contains at least 87 genes. Its sequence is composed of about 
54.5% G+C and includes all identified KSHV ORFs. The TR regions consist of multiple 
tandem 801-bp direct repeat units. These have 84.5% G+C content with potential 
packaging and cleavage sites (Russo et al., 1996). The genomes of KSHV and HVS are 
essentially co-linear and KSHV genes are named after their HVS counterparts. KSHV 
genes that are not homologous to genes of HVS are given a K prefix (e.g. ORF K1 to 
K15). Like HVS, KSHV encodes thymidine kinase, thymidylate synthase and 
dihydrofolate reductase. It is the only human herpesvirus, which contains all three of 
these genes. In addition to this, KSHV is also unusual in possessing a large number of 
genes encoding homologues of host genes. Many of the host genes that are expressed by 
KSHV are induced by other herpesviruses, most notably EBV. For example, KSHV 
encodes a homologue of cyclin D2 whereas EBV LMP-1 induces cyclin D2 in B-cells, 
which do not normally express this protein (Davis et al., 1997; Arvanitakis et al., 1995). 
The acquisition of host genes may enable KSHV to control host cell processes and avoid 
anti-viral responses.
1.4.2 Virus structure
Like other herpesviruses, KSHV has a nucleocapsid core surrounded by a tegument and a 
lipid envelope. Three-dimensional reconstruction of the KSHV capsid imaged by 
electron microscopy revealed a size and structural organisation similar to previously 
studied herpesviruses (Trus et al., 2001). Because of the difficulties in transmitting the
virus in vitro, little is known about the mode of cell entry or the cellular receptor for 
KSHV.
1.4.3 KSHV Gene Expression
As with other herpesviruses, KSHV gene expression can be classified into distinct kinetic 
stages. The temporal sequence of gene expression has been monitored by Northern blot 
and microarray analyses (Sun et al., 1999, Jenner et al., 2001).
Immediate early genes are expressed in the absence of de novo protein synthesis. Early 
gene expression is dependent on the products of immediate early genes binding to their 
promoters and driving early gene expression. Late gene expression begins at the onset of 
viral DNA replication. Latent gene expression occurs when the virus is in its latent 
cycle.
Latent gene expression
During latency few viral genes are expressed. Because KSHV is latent in the majority of 
cells that it infects, the genes that are expressed in latency may have a major role in the 
pathogenesis of KSHV associated cancer. Genes shown to be expressed during latency 
include v-cyclin, v-FLIP and Kaposin (Davis et al., 1997; Sturzl et al., 1999; Muralidhar 
et al., 1998). LANA-1 is also expressed which acts to tether the viral episomes to the 
host chromosomes (Rainbow et al., 1997; Kedes et al., 1997, Fejer et al., 2003).
Immediate early gene expression
A number of immediate early transcripts have been identified including those from the 
ORF50 gene (Zhu et al., 1999). Sequence comparison indicated that the ORF50 gene is
a homologue of the EBV BRLF1 gene, which encodes the EBV transactivator protein 
Rta (Sun et al., 1998). The ORF50 product has been demonstrated to activate the KSHV 
viral lytic cycle (Lukac et al., 1998; Gradoville et al., 2000, Xu et al., 2005).
Early gene expression
The ORF50 protein activates the expression of the ORFK8 gene (Chen et a l, 2000; 
Lukac et a l, 1998). The product of K8 is a bZip protein that shows homology to Zta, an 
EBV transactivator and origin binding protein (Fixman et a l 1995). Other early genes 
expressed are regulators of gene expression e.g. ORF57 and ORF45 (Zhu et a l, 1999).
Delayed early gene expression
The delayed early gene products include the conserved replication fork proteins that are 
required for viral DNA replication. These are the products of ORF6, the ssDNA binding 
protein; ORF9, the DNA polymerase; ORF59, the polymerase processivity factor; 
ORF56, the primase; ORF44, the helicase and ORF40/41, the primase associated factor. 
Although little is known about the lytic DNA replication of KSHV these proteins were 
shown to be able to substitute for their EBV counterparts, driving replication from the 
EBV origin of lytic replication (oriLyt) (Wu et a l, 2001).
Late gene expression
The late genes encode primarily structural proteins that are present at the late stage of the 
viral lytic cycle. Examples are the products from the K8.1A and K8.1B genes. 
Differential splicing of the K8.1 transcript gives rise to these two proteins. They are 
glycoproteins that are associated with the virion envelopes and the surfaces of transfected 
BCBL-1 and COS-1 cells (Zhu et a l, 1999b).
1.5 Herpesvirus DNA replication
1.5.1 Pathway of DNA replication in HSV-1
HSV-1 input genomes locate to structures in the cell nucleus called ND10 domains. As 
the lytic cycle of the virus progresses these structures become disrupted through the 
action of the immediate early viral protein ICPO (Everett et al., 1998; Everett and Maul,
1994). Pre-replicative sites form at the disrupted ND10 domains. These mature into 
replication compartments, which represent the sites of active viral DNA replication. 
Expression of the DNA replication proteins is followed by their localising into the 
nucleus, assembling onto the parental viral DNA in the pre-replicative sites and 
replicating the viral DNA (Lukonis and Weller, 1996; Lukonis and Weller, 1997; Liptak 
et al., 1996; Zhong and Hayward, 1997; Taylor et al., 2003;Taylor and Knipe, 2004).
The current model for HSV-1 DNA replication proposes that initial rounds of replication 
proceed via a theta-like mechanism, followed by a rolling-circle mode of replication at 
later times in infection (reviewed by Boehmer & Lehman, 1997). It had been reported 
that linear HSV-1 genomes were rapidly circularised following infection, probably via 
direct ligation of the complementary single overhanging nucleotides at their termini 
(Mocarski & Roizman, 1982; Poffenberger and Roizman, 1985; Garber et al, 1993). 
Circularisation overcomes the problems of replicating the genomic termini and a theta- 
like mechanism is consistent with exponential accumulation of viral DNA during early 
stages of DNA synthesis (Zhang et al., 1994). A rolling-circle mechanism of DNA 
replication later on in infection has been suggested by the prevalence of “endless” DNA, 
which restriction enzyme analysis indicated to consist of tandem head-to-tail 
concatemers (Jacob et a l, 1979; Severini et a l, 1994; Zhang et a l, 1994).
However, Jackson and Deluca (2003) have challenged this model. They failed to observe 
circularisation of HSV-1 genomes during productive infection and also observed that 
ICPO, which is known to be involved in the reactivation from latency, inhibited the 
formation of circular genomes. They suggest that HSV-1 may actually replicate its 
genome via a linear method. The genomic termini would be replicated following 
homologous recombination and concatemer formation similar to T4 and T7 
bacteriophage (Leider and Mosig, 1982; Richardson, 1983). Further evidence is required 
to support this model, and the circularisation of the genome during lytic infection has not 
yet been definitely excluded.
Once the viral DNA has been replicated, encapsidation occurs by a process in which 
cleavage of HSV progeny DNA concatemers into unit-length genomes and packaging of 
the DNA into the capsid are tightly linked (Varmuza and Smiley, 1985; Ladin et al., 
1982; Deiss et al., 1986).
1.5.2 DNA synthesis
DNA synthesis begins at defined sites within herpesvirus genomes, known as origins of 
replication. There is considerable variation in the size, sequence and structure of origins 
amongst the human herpesviruses suggesting that different mechanisms may be 
employed in the initiation of DNA synthesis. In contrast, the ORFs encoding essential 
replication fork proteins are amongst the conserved genes found in all herpesviruses, and 
once a replication fork has been established, DNA synthesis is presumed to proceed via a 
common mechanism. HSV-1 was the first herpesvirus in which the origins of replication 
and the proteins essential for viral DNA replication were identified. Having been 
extensively studied, it has become the model system for the study of herpesvirus DNA
replication and much of our knowledge regarding DNA replication in other herpesviruses 
has been inferred by analogy to HSV-1. Of the gammaherpesviruses, DNA lytic 
replication has been most extensively studied in EBV. As it is a comparatively close 
relative of KSHV its DNA lytic replication is also discussed.
The seven HSV-1 proteins found to be essential for origin-dependent viral DNA 
replication comprise an origin binding protein and six proteins that function at the 
replication fork. The replication fork proteins function as a ssDNA-binding protein, a 
heterodimeric DNA polymerase holoenzyme and a heterotrimeric complex possessing 
helicase and primase activity. Homologues of all of these six proteins, have been 
identified in all mammalian and avian herpesviruses sequenced to date, including the 
human herpesviruses EBV (Baer et al., 1984), HCMV (Chee et al., 1990), VZV 
(Davison & Scott, 1986) and KSHV (Wu et a l , 2001). The names and functions of the 
six conserved DNA replication proteins in HSV-1, and their proposed homologues in the 
human herpesviruses, are listed in Table 1.1.
1.5.3 Origins of replication
The lytic origins (oriLyt) of herpesviruses belonging to different subfamilies differ 
significantly and the OBP, unlike the other replication proteins, is not conserved. The 
alphaherpesviruses and the members of the roseolovirus genus of the betaherpesviruses 
have a distinct OBP that initiates DNA synthesis (Inoue et a l , 1994; Stow, 1982; Weller 
et a l , 1985; Elias & Lehman, 1988; Olivo et a l , 1988). The oriLyt of the 
gammaherpesviruses contains regions that are involved in transcriptional activation, and 
the OBP has roles both in transcriptional activation and the initiation of DNA synthesis 
(Schepers et a l , 1993; Schepers et a l , 1996; Lin et a l , 1999).
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1.5.4 HSV-1 origins of replication
HSV-1 contains two different origins of replication, known as oris and oriL(Stow, 1982; 
Weller et al., 1985). Oris is located in the inverted repeat sequence (TRs/IRs) which 
flanks the Us segment and hence two copies are present within the genome. One copy of 
oriL is present in the centre of the U l region. Although they vary in size, the sequences 
of oris and oriL are very similar. Each contains palindromic sequences centred around a 
region consisting of A and T residues only. The core region of oris is approximately 80 
bp and contains an imperfect 45 bp palindrome with a central 18 bp A+T region. Within 
and adjacent to the palindromic sequence flanking the A+T region of oris are three related 
sequences, box I, box II and box III, which are binding sites for the HSV-1 origin- 
binding protein, UL9. Box I (CGTTCGCACT) has the highest affinity for UL9, with a 
five-fold higher affinity than box II (TGCTCGCACT) and 1000-fold higher affinity than 
box III (CGTTCTCACT) (Olivo et al., 1988; Koff & Tegtmeyer, 1988; Elias et al.,
1990; Hazuda et al., 1991). (M l is larger and more symmetrical than oris and contains a 
perfect 144 bp palindrome with a 20 bp A+T central region. OriL contains one box I and 
one box III sequence on each arm of the palindromic sequence. Hence, oriL contains two 
very high affinity UL9-binding sites.
The functional significance of the presence of three origins of replication within the 
HSV-1 genome and the structural differences between oris and oriL is not known. There 
appears to be a degree of redundancy between oris and oHl as mutant viruses lacking 
either oriL or both copies of oris grow as well as wild type virus in cultured cells 
(Polvino-Bodnar et al., 1987; Igarashi et al., 1993). It is possible that they are differently 
activated depending on cell type. For example, oriL contains a functional glucocorticoid 
receptor binding site, which is involved in stimulation of its activity by dexamethosome
in nerve growth factor-differentiated PC-12 cells (Hardwicke and Schaffer, 1997).
1.5.5 HCMV origin of lytic replication
The HCMV lytic origin comprises a sequence spanning approximately 2.4 kbp near to 
the centre of Ul. This region contains the highest content of inverted and direct repeats in 
the HCMV genome (Anders et a l , 1992; Masse et a l , 1992). It includes various 
repeated sequence motifs, transcription factor binding sites including ATF, CREB and 
Sp-1, and also an AT rich segment. An oligopyrimidine sequence is also necessary for 
oriLyt function.
The possible role of transcription units in HCMV oriLyt function has been investigated 
(Huang et a l , 1996). Of particular interest was the identification of a series of short, 
non-polyadenylated transcripts called the smallest replicator transcript (SRT). Spanning 
approximately 0.22 kbp, with a common 5’ terminus and heterogeneous 3’ ends, SRTs 
are early transcripts driven by an upstream promoter. The structure of SRT suggests that 
it is not an mRNA, leading to the suggestion that it may have a role in the initiation of 
DNA synthesis. Recently a strong promoter with bidirectional activity was located 
within the core region of the oriLyt, which is required for efficient amplification of 
oriLyt (Xu et a l , 2004).
1.5.6 EBV Origin of lytic replication
The EBV genome has two copies of oriLyt containing two essential core elements and an 
auxiliary domain. One core element contains Zta responsive elements (ZREs) for the
transactivator protein Zta, which were shown to be absolutely required in a transient- 
transfection assay (Hammerschmidt and Sugden, 1988; Schepers et a l, 1993; Schepers et 
a l, 1996). The other core element contains two AT rich palindromes and an adjacent 
polypurine-polypyridimine tract. The auxiliary domain is an enhancer region containing 
DNA binding sites for Rta (viral transactivator) and Zta. Rta is not essential for oriLyt 
dependent DNA synthesis but it has a significant stimulatory effect on replication 
efficiency (Fixman et a l, 1995). Whilst the core region ZREs are essential for 
replication, the enhancer region ZREs are dispensable (Schepers et a l, 1996). The 
regions of Zta that are critical for the Zta-mediated DNA replication are nearly identical 
to regions that have previously been identified to be crucial for transcriptional activation 
of Zta dependent promoters.
1.5.7 Essential DNA replication proteins in HSV-1
The identification of the HSV-1 origins of replication enabled investigation of the 
identity of the viral-encoded proteins involved in DNA synthesis. A series of plasmids 
containing cloned fragments of the HSV-1 genome were tested for their ability to support 
replication of a plasmid containing an HSV-1 origin of replication when all were co­
transfected into cells. This led to the identification of six fragments of HSV-1 DNA, 
which supplied the necessary trans-acting functions required to replicate the transfected 
origin (Challberg, 1986). Systematic sub-cloning of these fragments resulted in the 
identification of seven viral genes, which were necessary and sufficient for origin- 
dependent replication (Wu et a l, 1988). The results of the transient assay were in 
agreement with detailed mapping of DNA negative mutant HSV-1 viruses (reviewed by 
Boehmer & Lehman, 1997) and were confirmed by the demonstration that replication of 
an origin-containing plasmid is supported by infection of S f  cells with recombinant
baculoviruses expressing the seven replication proteins (Stow, 1992).
The HSV-1 DNA polymerase isolated from HSV-1 infected cells is a heterodimer 
consisting of the UL30 and UL42 proteins (Vaughan et al., 1985). UL30 (pol) is the 
catalytic sub-unit, which has been extensively studied. It shares sequence similarity to 
other DNA polymerases, and hence has also been studied as a model eukaryotic DNA 
polymerase. In addition to its polymerase function, UL30 possesses a 3’->5’ 
exonuclease activity and RNase H activity (Knopf, 1979; O’Donnell et al., 1987; Crute 
& Lehman, 1989). These properties are presumed to confer a proof-reading activity and 
the ability to remove RNA primers during the processing of Okazaki fragments.
UL42 is a phosphoprotein with sequence-independent ds DNA-binding activity that 
associates with UL30 and serves to increase its processivity (Gallo et al., 1988; 
Hernandez & Lehman, 1990; Gallo et al., 1989; Gottlieb et al., 1990). It is monomeric in 
solution and binds to ssDNA as a monomer (Randell and Coen, 2004). It was thought 
that by interacting with UL30 and ds DNA simultaneously, UL42 tethers UL30 to the 
template, enabling the synthesis of long DNA chains (Gottlieb & Challberg, 1994). 
However, Chaudri and Parris (2002) suggest that the interaction between UL30 and 
UL42 may change the conformation of UL30 so that UL30 has a more closed 
conformation around the DNA. This would result in UL30 having a stronger attachment 
to the DNA and would therefore increase processivity. The interaction between UL30 
and UL42 is mediated by a short sequence (35aa) at the C-terminus of UL30 and appears 
to be critical for DNA replication. Deletion of this sequence has no effect on the DNA 
polymerase activity of UL30 but abolishes its ability to support long chain synthesis 
(Digard et al., 1993; Tenney et al., 1993) and origin-dependent DNA replication (Stow,
1993).
Essential helicase and primase functions in HSV-1 infected cells are provided by a 
heterotrimeric complex comprised of the UL5, UL52 and UL8 proteins (Crute et al, 
1989). The 5’->3’ helicase has associated ATPase and GTPase activities (Crute et al 
Lehman, 1991). The primase exhibits strong sequence preference for the 
synthesis of short oligoribonucleotide primers of between 8-10 bases (Tenney et al., 
1995; Crute & Lehman, 1991). The UL5 protein contains six motifs characteristic of 
helicases and UL52 contains a sequence motif similar to that found in other DNA 
primases (McGeoch et a l , 1988), hence the helicase and primase functions have been 
assigned to the UL5 and UL52 subunits, respectively. A sub-assembly of the UL5 and 
UL52 proteins displays both helicase and primase functions (Calder & Stow, 1990; 
Dodson & Lehman, 1991). In addition, site-directed mutagenesis studies have 
demonstrated that the helicase and primase active sites reside within the UL5 and UL52 
components, respectively (Zhu & Weller, 1992; Klinedinst & Challberg, 1994), although 
neither protein alone exhibits significant enzymatic activity. More recently it was shown 
that the two proteins demonstrate an interdependence for DNA binding and that the 
UL52 protein may have a more active role in helicase activity than previously thought 
(Biswas and Weller, 2001).
The role of the UL8 protein was initially unclear, as it does not appear to perform any 
obvious enzymatic functions and does not bind to DNA (Parry et a l , 1993). Several 
studies have now indicated it is likely that UL8 has several auxiliary roles at the 
replication fork. It is known to be necessary for efficient primer utilisation by the 
polymerase in a model of lagging strand synthesis (Sherman et a l , 1992), to stimulate 
primer synthesis (Tenney et a l , 1994) and is required for efficient nuclear translocation 
of the helicase-primase complex (Calder et al., 1992; Marsden et a l , 1996). UL8 is 
known to interact with several other replication proteins, indicating a multifunctional role
at the replication fork.
UL9 functions as an origin-binding protein, involved in the initiation of DNA replication. 
It exists as a homodimer in solution, binds to specific sequences present in HSV-1 
origins (Elias & Lehman, 1988; Olivo et al., 1988) and possesses DNA-dependent 
ATPase and helicase activities (Fierer & Chalberg, 1992; Boehmer et al., 1993). The 
amino-terminal portion of the protein mediates the helicase, ATPase and dimerisation 
activities whilst the carboxy-terminal domain is involved in sequence-specific DNA 
binding. The non-sequence specific helicase activity of UL9 appears to be required for 
DNA synthesis as the introduction of mutations into the helicase motifs renders the 
protein unable to support DNA replication (Martinez et al., 1992). Binding of UL9 to 
sites I and II in oris is co-operative, indicating that an interaction occurs between UL9 
protein(s) bound at each site (Elias et al., 1990). The helicase activity of UL9 is 
stimulated by the ssDNA-binding protein, ICP8, by its interaction with UL9 (Fierer & 
Challberg, 1992; Lee and Lehman 1997). An interaction has also been demonstrated 
between UL9 and UL42, which also stimulates the helicase activity of UL9 (Monahan et 
a l , 1998; Trego and Parris, 2003).
ICP8 (UL29) is the ssDNA binding protein in HSV-1. As it is the homologue of KSHV 
pORF6 and it has been extensively studied, a detailed review of it is given in section 
1.7.2.
1.5.8 Essential DNA replication proteins in EBV
Homologues of six of the core replication proteins found in HSV-1 are also encoded by 
EBV (Fixman et a l, 1992). These are the DNA polymerase (BALF5) and its accessory
factor (BMRF1), the ssDNA binding protein (BALF2), the helicase (BBLF4), the 
primase (BSLF1) and the primase-associated protein (BBLF2/3). Their functions are 
sufficiently conserved that the HSV-1 homologues in the presence of Zta and Rta can 
drive replication from EBV oriLyt (Fixman et a l, 1995).
The polymerase and polymerase accessory protein have been shown to interact by co- 
immunoprecipitation, and together mediate DNA replication with strand displacement in 
model replication systems (Kiehl and Dorsky, 1991; Lin et a l, 1991; Tsurumi et a l, 
1993; Tsurumi et a l, 1997). The holoenzyme exhibits both 5’ to 3’ DNA polymerase 
and 3’ to 5’ exonuclease activities (Tsurumi, 1991).
BALF2 is the homologue of pORF6. It binds with limited cooperativity to ssDNA and 
functions to melt out secondary structure from ssDNA, which facilitates the activity of 
the DNA polymerase (BALF5). The presence of BALF2 eliminates pausing by BALF5 
during DNA replication (Tsurumi et a l, 1996). BALF2 has been found to contact the 
DNA polymerase (Zeng et a l, 1997) and also possibly the helicase-primase complex 
(Gao et a l, 1998). The latter interaction has been shown to be necessary in HSV-1 for 
localising the ssDNA binding protein (ICP8) to pre-replicative sites (described in section 
1.5.11) (Liptak et a l, 1996; Lukonis et a l, 1997).
In addition to being a transcriptional activator, Zta also acts as the OBP. A cotransfection 
assay in EBV negative cells showed that Zta (in addition to the six conserved replication 
fork proteins) was absolutely required for replication from EBV oriLyt (Fixman et a l,
1995). Mutation of the four Zta binding sites in the promoter region abolished oriLyt- 
dependent replication (Schepers et a l, 1996). An interaction between Zta and the 
helicase-primase complex has been demonstrated (Gao et a l, 1998). This interaction
between the helicase protein of the helicase-primase complex and Zta has been mapped 
to aa 22 to 86 of the Zta protein, (Liao et a l , 2001).
Interactions between the helicase-primase subunits were demonstrated by 
immunofluorescence assays. Expressed individually, the proteins showed either mixed 
nuclear and cytoplasmic, or cytoplasmic staining. When all three proteins were 
transfected, nuclear localisation of all three was observed (Gao et a l , 1998). Co- 
immunoprecipitation experiments revealed that each component of the BBLF4-BSLF1- 
BBLF2/3 complex directly interacts with the other two (Yokoyama et a l , 1999).
In addition to interacting with Zta, the helicase-primase has also been shown to interact 
with the polymerase through both the BSLF1 and BBLF2/3 subunits. (Fujii et a l , 2000). 
The polymerase interacts with its accessory factor, which in turn binds to Zta (Zhang et 
a l , 1996). Co-immunoprecipitation assays have also demonstrated an interaction 
between the helicase-primase associated factor and the cellular zinc finger protein 
ZBKR1, which binds to EBV oriLyt. It has been suggested that ZBKR1 may be acting 
as a tethering point on oriLyt for the replication complex, through its interaction with the 
helicase-primase complex. (Liao et a l , 2005).
1.5.9 Host cell-encoded functions involved in HSV-1 DNA replication
HSV-1 DNA replication is largely autonomous from the host cell, however, several 
essential functions are not encoded by HSV-1 and are therefore assumed to be provided 
by host cell enzymes. For example, a topoisomerase is expected to be required to 
remove supercoils from replicating DNA, and a DNA ligase for joining the Okazaki 
fragments produced during lagging strand synthesis.
1.5.10 Model for origin unwinding and initiation of DNA replication in HSV-1
Using the information that has been gathered regarding the HSV-1 origins, replication 
proteins and how they interact with each other, a model for the unwinding of the 
replication origin and establishment of a replication fork has been proposed (Boehmer & 
Lehman, 1997 and Stow, 2000), however, it should be noted that not all the events 
proposed have been substantiated experimentally. Although the initial events in 
unwinding the replication origins may vary amongst the different herpesviruses, the 
subsequent recruitment of DNA replication proteins and establishment of a replication 
fork may follow a similar pathway to that which is proposed for HSV-1. Steps 1-3 are 
illustrated in figure 1.3.
1) The initial step involves the binding of UL9 to recognition sites (box I and/or II) on 
either side of the AT region at the centre of oris and oriL.
2) Bound UL9 proteins interact with each other, possibly mediated by a leucine zipper 
motif within the N-terminal region of UL9. This interaction results in a distortion of 
the DNA helix in the AT region between the binding sites. Specifically, it has been 
suggested that the intervening DNA is held in a loop configuration as a result of the 
interaction (Koff et al., 1991).
3) The interaction between UL9 and ICP8 serves to recruit ICP8 to the origin, where it 
binds to the distorted DNA in the AT region. ICP8 stimulates the sequence 
independent helicase activity of UL9 and increases its processivity allowing 
unwinding of the duplex DNA adjacent to the origin. The interaction between UL9 
bound to the opposite sides of the origin is maintained during initial unwinding and 
ssDNA extruded from the UL9-ICP8 complex is stabilised by coating with ICP8. 
Sequence specific unwinding of an HSV-1 origin by UL9 has been demonstrated 
only in the presence of ICP8, indicating the importance of the UL9-ICP8 interaction
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to the unwinding process (Lee & Lehman, 1997).
4) Once unwinding of the duplex DNA has begun, recruitment of the helicase-primase 
and polymerase functions is necessary for DNA synthesis to commence. It is 
postulated that the arrival of the helicase-primase and polymerase enzyme complexes 
result in either the displacement of UL9, or disruption of the interaction between UL9 
proteins, allowing the origin to take the form of a replication bubble. It is probable 
that the helicase-primase heterotrimer is recruited via protein-protein interactions 
involving the UL8 component, as UL8 physically interacts with UL9 (McLean et al.,
1994) and an interaction with ICP8 is also strongly suggested (Falkenberg et al.,
1997; Tanguy Le Gac et al., 1996).
5) The helicase-primase complex then directs the synthesis of short RNA primers on 
both unwound DNA strands for elongation by the DNA polymerase holoenzyme.
6) Recruitment of the polymerase holoenzyme to the sites of unwound and RNA-primed 
DNA is possibly mediated through interactions of the polymerase holoenzyme with 
UL9 and or the UL8 subunit of the helicase-primase complex. The polymerase 
accessory protein, UL42, specifically interacts with the N-terminal region of UL9 
(Monahan et al., 1998) and this interaction may also contribute to the proposed 
dissociation of UL9 to allow formation of a replication bubble. The other interaction, 
which may be involved in recruitment of polymerase occurs between UL30 (catalytic 
subunit) and the UL8 subunit of the helicase-primase complex. Characterisation 
studies indicate that the region spanning the C-terminal 32 amino acids of UL8 is 
involved in the interaction (Marsden et al., 1997). It is interesting to note, therefore, 
that a UL8 mutant lacking the C-terminal 33 residues does not support origin- 
dependent replication (Barnard et al., 1997), supporting the hypothesis that the UL8- 
UL30 interaction may be crucial for DNA synthesis.
7) Once polymerase has been recruited to the replication fork, the RNA primers are
extended and bi-directional DNA synthesis is established. The helicase-primase 
complex proceeds to further unwind the duplex DNA and synthesise primers for 
lagging strand synthesis as the replication fork moves away from the origin.
1.5.11 HSV-1 Replication fork
As replication progresses the remaining six DNA replication proteins (UL5/UL52/UL8, 
UL30/UL42 and ICP8) may function together as a multiprotein complex co-ordinating 
DNA synthesis on the two strands. A complex of these six proteins was shown to be able 
to carry out rolling-circle type DNA synthesis on circular plasmid templates (Skaliter and 
Lehman, 1994).
A model for the DNA replication fork has been proposed in which the lagging strand is 
looped in a manner such that the leading and lagging strand DNA polymerases can both 
move along the DNA in the same direction as the replication fork. In the case of HSV-1 
this would allow a UL5-UL8-UL52 trimer to unwind the duplex DNA and prime lagging 
strand DNA synthesis (Figure 1.4) (Stow, 2000). The UL8-ICP8 interaction may serve 
to direct the helicase-primase complex to regions of ssDNA and to modulate the 
enzymatic activities of the complex. ICP8 stimulates the DNA-dependent ATPase and 
helicase functions of the complex (Hamatake et al., 1997), and efficient helicase-primase 
activities on ICP8-coated templates are dependent on the presence of UL8 (Falkenberg et 
al., 1997; Tanguy Le Gac et al., 1996). The UL8-UL30 interaction probably has a role in 
the co-ordination of DNA unwinding and leading strand synthesis and also co-ordinates 
the synthesis of RNA primers with lagging strand synthesis.
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1.5.12 Recombination events in HSV-1
During replication of the HSV-1 genome events such as DNA damage may lead to 
double-stranded breaks and the collapse of the replication fork. To repair these and 
continue replication a recombination strategy may be employed. Recombination is also 
responsible for the genomic inversions during replication in which the U l and the Us 
components invert their relative orientation. Homologous recombination between co- 
infecting viruses has also been well documented (Schaffer et al., 1974; Honess et al., 
1980; Umene, 1985; Brown et al., 1992). Two viral proteins that have been implicated 
in these processes are the alkaline nuclease (UL12) and the ssDNA binding protein 
(ICP8). Possible mechanisms for recombination are discussed in section 1.7.2
1.6 KSHV lytic DNA replication
1.6.1 KSHV origin of lytic replication
Two duplicated copies of the DNA replication origin (oriLyt) have been identified 
(AuCoin et al., 2002). They are located between K4.2 and K5 and between K12 and 
ORF71. The two ori-Lyt share an almost identical 1.1 kb sequence and 600 bp GC rich 
repeats. The whole 1.7 kb DNA sequences are necessary and sufficient for lytic 
replication (Lin et al., 2003). Within these sequences the most important c/5-acting 
elements have been shown to be eight C/EBP (CCAAT/enhancer binding protein) 
binding motifs, arranged as four spaced palindromes; an 18 bp AT palindromic sequence 
where local unwinding of ds-DNA during initiation of replication is thought to occur, and 
an ORF50/Rta-dependent promoter that is composed of Rta response element and a 
TATA box. These lytic origins closely resemble the lytic origin of the rhesus macaque 
rhadinovirus (Pari et al., 2001) with both having GC-rich regions adjacent to an AT-rich 
domain.
The lytic origin and the trans-acting factors involved in KSHV DNA replication were 
investigated further by AuCoin et a l (2004). The use of site directed mutant plasmids in 
a transfection replication assay revealed that the AT-rich sequences, three API 
transcription factor binding sites and a downstream component containing an ORF50 
response element and a TATA box were necessary for efficient replication of oriLyt 
(figure 1.5). The organisation of the lytic origin is similar to that of EBV and the API 
transcription binding sites in EBV function as Zta response elements. The ORF50 
response elements were further investigated in this study. The use of luciferase reporter 
constructs containing the ORF50 response element revealed that they were responsive to 
K-Rta (ORF50 product) and that it is a region of active transcription within the viral 
genome. The EBV oriLyt also contains two Rta binding sites.
1.6.2 KSHV DNA replication proteins
Although a homologue of the OBP in HSV-1 (UL9) has not been identified, the HHV8 
encoded protein- K8, has been shown to bind to the oriLyt and may be serving as an 
initiator protein. K8 is thought to be a homologue of Zta (OBP for EBV). The two 
proteins have limited sequence homology, corresponding genomic locations, similar 
splicing patterns and are both members of the bZIP family (Lin et a l , 1999). Although 
no direct interaction has yet been proven between K8 and the other KSHV replication 
proteins, K8 has been shown to co-localise with a KSHV viral DNA replication complex 
comprising the KSHV homologues of the six conserved herpesvirus replication fork 
proteins (Wu et a l , 2001). These are the protein products of ORF6, the ssDNA binding 
protein (SSB); ORF9, the DNA polymerase (Pol); ORF59, the polymerase processivity 
factor (PPF); ORF56, the helicase (HEL); ORF44, the primase (PRI) and ORF40/41 the 
helicase-primase associated factor (PAF).
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Wu et a l (2001) also investigated the nuclear location of these proteins and the 
formation of KSHV replication compartments. When expressed individually in Vero 
cells, SSB and PPF were transported to the nucleus and diffuse nuclear staining was 
observed. POL, HEL and PRI were localised in the cytoplasm, whereas PAF gave a 
mixed but predominantly cytoplasmic staining. Cotransfection of POL with PPF was 
sufficient to translocate POL to the nucleus. Complete nuclear staining of PAF required 
all six proteins to be present.
In the presence of all six core replication proteins pseudo-replication compartments that 
excluded cellular DNA were formed. On co-transfection with a plasmid containing the 
EBV oriLyt and Zta, newly synthesised EBV oriLyt plasmid DNA was observed, 
confirming that these pseudo replication compartments could accommodate DNA 
replication and that the EBV and KSHV replication fork proteins were interchangable. 
Inspection of KSHV infected cells undergoing lytic infection demonstrated similar 
replication compartment structures that contained newly synthesised DNA and co­
localised with K8 (Wu et a l , 2001).
A cotransfection replication assay demonstrated that in addition to the core conserved 
herpesvirus DNA replication proteins, K-Rta and K8 were also required for replication of 
KSHV oriLyt to be detected. The regions of K8 that were essential for DNA replication 
were explored. Mutation of the leucines within the leucine zipper motif demonstrated 
that this region of the protein is essential for its activity and for efficient oriLyt 
dependent DNA replication. This study demonstrated that although K8 may be the 
primary origin binding protein, K-Rta may also have a role in DNA replication from 
oriLyt (Aucoin et a l , 2004).
A recent study using a KSHV mutant that had a large deletion in the ORF50 gene (K- 
Rta) further demonstrated that K-Rta is required for lytic viral reactivation and also the 
transactivation of viral genes contributing to DNA replication (Xu et al., 2005). This is 
in contrast to EBV where the K8 homologue Zta drives the lytic cycle. Zta also performs 
essential transactivation and DNA replication functions within EBV oriLyt whereas K8 
does not appear to have a corresponding transactivation function.
To date, the only interaction between KSHV replication proteins that has been studied in 
detail, is between the polymerase (Pol) and its processivity factor (PPF). To determine 
whether the interaction between the two proteins was functionally significant, the DNA 
synthesis activity of pol in the presence and absence of PF was investigated using primed 
M l3 ssDNA as the template in an in vitro DNA synthesis assay (Lin et al., 1998). In the 
absence of PF, Pol could only incorporate a few nucleotides. PF was required for pol to 
synthesize extended DNA products. The effect of the PF from HSV-1 (UL42) on KSHV 
pol was also tested. UL42 was not able to confer processivity on pol demonstrating that 
the functional interaction between KSHV pol and PF is specific.
To confirm that pol and PF physically interacted the two were successfully co- 
immunoprecipitated (Chan and Chandran, 2000). The pol binding domain of PF was 
then investigated using PF deletion mutants demonstrating an essential role for amino 
acids 10-27 in the interaction with pol.
1.7 Single stranded DNA binding proteins
1.7.1 General
KSHV pORF6 belongs to the family of single-stranded DNA binding proteins (SSB).
The most extensively studied of this class are SSB from E.coli, DBP (DNA binding 
protein) from adenovirus, gp 32 (gene 32 protein product) from bacteriophage T4, gp 2.5 
(gene 2.5 protein product) from bacteriophage T7 and RPA (Replication protein A), the 
eukaryotic SSB. These proteins are involved in recombination, repair and replication. 
They bind to ssDNA in preference to dsDNA in a sequence independent manner.
Recognition of DNA is mediated by their OB-fold (apart from the adenovirus DBP, the 
only SSB identified to date without an OB-fold). The OB-fold is a small structural motif 
originally named for its oligonucleotide/oligosaccharide binding properties (Murzin, 
1993). They range in length from 70 to 150 amino acids and there is only a low degree 
of sequence similarity among them (Wutte et al., 2003). However, the fold has a distinct 
topology. It consists of two three-stranded anti-parallel P-sheets, where strand 1 is 
shared by both sheets. The proteins interact with nucleic acids mostly through stacking 
interactions with aromatic amino acid side chains, electrostatic charge interactions and 
packing interactions with hydrophobic side chains or the aliphatic portions of polar 
groups such as lysine and arginine (Kelly et a l , 1976; Prigodich et a l , 1984; Curth et a l , 
1993; Kim and Richardson, 1993; Kallenpoulos et a l , 1995).
The adenovirus DBP and T4 gp 32 are monomeric up to a certain concentration where 
they self-associate to form dimers and higher molecular weight aggregates (Schechter et 
a l, 1980; Alberts and Frey, 1970; Carroll et a l 1972). Gp 2.5 (T7) exists as a dimer 
(Kim and Richardson, 1994) and the E.coli SSB assembles as a homotetramer (Molineux
et a l, 1974; Weiner et a l, 1975). The eukaryotic RPA is a heterotrimeric protein (Wold 
and Kelly, 1988).
Binding to ssDNA is in a cooperative fashion and facilitates their activity. (Alberts and 
Frey, 1970; Kuil et a l, 1989; Lohman and Overman, 1985; Kim and Wold, 1994). Helix 
destabilisation is promoted since the binding of one molecule to the exposed ssDNA 
region, increases the affinity of others, helping to prevent renaturation of the two 
strands. During elongation of the DNA, covering of the ssDNA template not only aids 
the polymerase by removing secondary structure from the DNA but it also protects the 
DNA from nuclease digestion (figure 1.6). Gp 2.5 may stimulate the T7 DNA 
polymerase, not just by removing secondary structure from DNA, but also by a direct 
physical interaction (Kim et a l, 1992; He et a l, 2003). An interaction has also been 
demonstrated between eukaryotic RPA and DNA polymerase alpha (Domreiter et a l  
1992).
The C-terminal region of the adenovirus DBP appears to be important for protein-protein 
interactions that aid cooperative binding. DBP has a C-terminal arm that hooks onto a 
second DBP monomer, which results in the formation of long protein chains along the 
ssDNA (Tucker, 1994). Conversely, the region required for cooperative binding in gp 32 
(T4) lies at the very N-terminus of the protein (Spicer et a l, 1979; Lonberg et a l, 1981). 
The cooperative binding domain of the E.coli SSB also lies in the N-terminal region 
(Williams et a l, 1984).
Another feature of gp32 (T7) is its ability to bind to RNA and possibly control gene 
expression at the level of translation. The specificity of gp32 for gp32 mRNA and not 
other T4 mRNA lies in a uniquely structured region that spans 50nt ( Krisch et al., 1982).
DNA
polymerase
Single-stranded region o f 
DNA template with short 
regions o f  base-paired 
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Single-strand binding 
protein
Protein binding 
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-------
DNA is protected from 
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As the polymerase moves along the DNA template the ssDNA binding protein 
is displaced.
Figure 1.6 The effect of single-strand DNA-binding proteins on the structure of 
single-stranded DNA
As each protein molecule prefers to bind next to a previously bound molecule, long rows 
o f the protein form on a DNA single strand. This cooperative binding removes secondary 
structure from the DNA template and facilitates the DNA polymerisation process.
Gp 32 has a higher affinity for ssDNA than its mRNA ensuring that all ssDNA is 
saturated before it will bind to its mRNA to control its own expression level (Krisch et 
a l , 1974; Russel et a l , 1976; Newport et a l , 1981). SSB (E.coli) and DBP (adenovirus) 
also bind to RNA with a lower affinity than they bind to ssDNA and may also have a role 
in controlling their own expression levels (Molinuex et a l , 1975; Cleghon and Klessig, 
1986). Eukaryotic RPA can also bind to RNA but again with a lower affinity than it 
binds to ssDNA (Kim et a l , 1992).
SSBs also have a role in recombination and repair. Recombination and replication are 
coupled events, and homologous recombination is a strategy used to repair double­
stranded breaks in the DNA. The SSB of E.coli aids the RecA protein in strand exchange 
by removing secondary structure from the DNA (Kowalczyowski et a l , 1987; Lavery 
and Kowalczyowski, 1992). T4 gp32 has been demonstrated to aid strand exchange 
(George et a l , 2001) and T7 gp2.5 has been shown to be involved in DNA annealing 
(Kong and Richardson, 1996; Kong and Richardson, 1998). The adenovirus DBP 
enhances DNA renaturation (Zijderveld et a l , 1993). RPA has been shown to be 
required for strand exchange. (Moore et a l  1991).
1.7.2 ICP8
ICP8 is the HSV-1 homologue of KSHV pORF6 , the protein studied in this thesis, and is 
the most extensively studied of the SSBs from the herpesviruses. It is a zinc 
metalloprotein with a MW of approximately 128 kDa (Ruyechan, 1983). The zinc 
enhances structural integrity and is not involved in binding to DNA (Gupte et a l , 1991). 
Like other proteins in this family (SSBs) ICP8 has a role in recombination, repair and
replication. It has helix destabilising properties and has a higher affinity for ssDNA than 
ds-DNA (Boehmer and Lehman, 1993; Purifoy and Powell, 1976).
During initiation of replication ICP8 is believed to bind to the C-terminal domain of the 
OBP at the origin of replication and assists in the ATP-dependent unwinding of the 
origin (Boehmer and Lehman, 1993; Boehmer et a l , 1994; Makhov et a l , 1996; Lee and 
Lehman, 1997) (figure 1.3). As elongation of the DNA proceeds, ICP8 is proposed to act 
at the replication forks to hold the DNA in an extended conformation, facilitating the 
activity of the DNA polymerase and also protecting exposed ssDNA from nuclease 
attack. ICP8 also interacts with the UL8 subunit of the helicase-primase and stimulates 
the helicase activity of this complex (Tanguy le Gac et a l , 1996; Hamatake et a l, 1997).
Whilst a direct physical interaction between ICP8 and the HSV-1 polymerase has not 
been demonstrated, a functional interaction was shown by ICP8 stimulating the 
enzymatic activity of the DNA polymerase (O’Donnell et a l, 1987). ICP8 is also 
required for the polymerase to localise to pre-replicative sites within the HSV-1 infected 
cell, demonstrating another functional interaction (Bush et a l, 1991).
Like other SSBs, aromatic and basic residues mediate protein-nucleic acid contacts via 
stacking and electrostatic interactions (Ruyechan and Olson, 1992). The binding site size 
has been reported to be between 12-40 nt per monomer (Ruyechan, 1983; O’Donnel et 
a l, 1987 ; Gustafasson et a l, 1995; Bortner et a l, 1993; Makov et a l, 1996; Dudas and 
Ruyechan, 1998). This lack of agreement may be due to differences in experimental 
technique, concentration of protein used or differences between protein preparations.
The use of deletion mutants and photoaffinity labelling has placed the minimum region 
for binding between amino acids 332 to 902 (Leinbach and Heath, 1989; White and
Boehmer; 1999). Within this stretch lies the predicted zinc finger motif between amino 
acids 499 and 512 (Gupte et a l, 1991).
ICP8 binds to ssDNA in a cooperative manner, which induces a conformational change 
in the protein (Ruyechan, 1983; Lee and Knipe, 1985; Dudas et a l, 2001). The region of 
the protein that is responsible for mediating the protein-protein interactions required for 
cooperative binding includes the C-terminal 60-residues (Mapelli et al., 2000). The C- 
terminus additionally contains a nuclear localisation signal (Gao and Knipe, 1992). 
Binding to ssDNA is optimal at 150mM NaCl and neutral pH (Ruyechan and Weir,
1984).
The crystal structure of ICP8 has recently been resolved (Mapelli et a l, 2005). The 
protein preparation used was not the whole protein (1196aa) as this had previously failed 
to yield well deffacting crystals, but a deletion mutant lacking the C-terminal 60 residues. 
The structure is composed of a large N-terminal domain (9-1038) and a smaller C- 
terminal a-helical domain (figure 1.7). The N-terminal domain is described as consisting 
of head, neck and shoulder regions. The neck region contains a structure similar to the 
OB fold, which mediates ssDNA binding and has been found in all SSBs described to 
date (except for adenovirus SSB). Although the C-terminus was missing 60 residues, the 
C-terminal domain fits loosely into a concave surface on the back of the N-terminal 
domain, revealing the structure that confers co-operativity of ICP8 binding to ssDNA. It 
is thought that the C-terminal 60 residues would reach round and bind to a hydrophobic 
region on the N-terminal domain, stabilising this interaction.
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Figure 1.7 Structure of ICP8
A Overall view o f the ICP8 structure. Dotted lines represent disordered regions with blue and 
red balls signifying the N and C-terminal ends o f the disordered regions. The shoulder region 
is blue, the zinc binding region is green, the part o f the polypeptide chain linking the neck and 
shoulders as a single folding unit is orange. The neck is coloured yellow (front) and grey 
(back). The head is red and the C-terminal helical domain is purple.
B The structure rotated 60° along x-axis relative to A. In this orientation the C-terminus is 
behind the neck, (from Mapelli et al., 2005).
As previously mentioned, ICP8 and UL12 together are capable of catalysing an in vitro 
strand exchange reaction. Further studies demonstrated that ICP8 has a strong 
recombinase activity and it has been likened to other recombinases such as RecA, UvsX 
and Rad 51 (Reuven et a l , 2004). Likes these recombinases, ICP8-ssDNA filaments are 
helical, and in solution, in the absence of DNA it forms helical self-filaments.
ICP8 , in conjunction with the viral helicase-primase, has been shown to catalyse strand 
exchange (Nimonkar and Boehmer, 2002). In contrast to the work from Reuven et al. 
(2004) this was UL12 independent. Also demonstrated was its ability to promote the 
assimilation of ssDNA into homologous supercoiled DNA, resulting in the formation of a 
displacement loop (Nimonkar and Boehmer, 2003). Renaturation of complementary 
DNA strands by ICP8 has also been shown (Dutch and Lehman, 1993).
A co-immune-precipitation study of HSV-1 infected cells, using ICP8 monoclonal 
antibodies revealed a number of cellular proteins that co-precipitated with ICP8 (Taylor 
and Knipe, 2004). The majority of the proteins were components of cellular complexes 
that coordinate DNA recombination and repair. HSV-1 may recruit some of these 
cellular proteins to participate in HSV-1 replication and also the repair of damaged viral 
DNA that may arise during replication.
ICP8 also has a role in viral transcription, affecting it in at least two ways. It can repress 
transcription from input parental viral genomes and can also stimulate late gene 
transcription (Godowski and Knipe, 1985; Gao and Knipe 1991). An interaction between 
ICP8 and ICP27 has been established (Zhou and Knipe, 2002; Olesky et al., 2005).
ICP27 stimulates expression of some early viral genes and transcription of some late 
viral genes. The two proteins were also shown to associate with cellular RNA
polymerase II, which is responsible for transcription of all of the viral genes. It is 
hypothosised that the ICP27-ICP8 interaction plays a role in the stimulation of late gene 
transcription.
A direct interaction between ICP8 and RNA has recently been demonstrated which 
provides a possible molecular basis for the role of ICP8 in the regulation of viral gene 
expression. (Boehmer, 2004). Its ability to form R-loops may also be related to its role in 
recombination. R-loops are triple stranded structures formed between RNA and duplex 
DNA in which the RNA strand displaces the DNA strand of identical sequence (Kabak et 
al., 1979). The RecA protein from E.coli uses R-loops to initiate recombinatorial repair 
of DNA breaks (Kasahara et al., 2000; Zeitsev and Kowalczykowski, 2000)
1.8 Aims
There has been little work carried out so far on the core set of six replication proteins that 
are required for the DNA replication of KSHV. To date the protein product of the KSHV 
ORF6 gene (pORF6) had not been purified and characterised. The aims of this project 
were to firstly over-express and purify pORF6 and then to characterise its binding to 
ssDNA.
Initial work involved the generation of a baculovirus expression system in which the 
protein could be expressed to a high level. Successful expression led to the purification 
of the protein by column chromatography. Preliminary experiments demonstrated that 
the purified pORF6 could bind to ssDNA. Characteristics of binding were then 
investigated by electrophoretic mobility shift assay (EMSA) and surface plasmon 
resonance. A panel of monoclonal antibodies (MAbs) against pORF6 were also 
generated and characterised, and studies were initiated to examine the effects of the 
MAbs on the interaction of pORF6 with ssDNA.
Chapter 2 
Materials and Methods
2.1 Materials
2.1.1 Chemicals and reagents
All chemicals were obtained from Sigma Chemicals Company or BDH Laboratory 
Supplies with the following exceptions;
Amersham Pharmacia Biotech (APB)
BIAcore
Roche
Bio-Rad Laboratories
Calbiochem Corporation 
Prolabo
New England Biolabs 
Smithkline Beecham Research
ECL western blotting detection reagents, 
Rainbow protein MW markers
Surface plasmon resonance chips and buffer
Tris base, Nonidet-P40, complete EDTA- 
free protease inhibitor tablets
Ammonium persulphate, 30 % 
acrylamide/bis-acrylamide solution, protein 
assay dye reagent concentrate
Clelland’s reagent (DTT)
Methanol
Lambda DNA-BstE II digest markers 
Ampicillin
2.1.2 Enzymes
Enzymes were obtained from:
New England Biolabs, USA : T4 polynucleotide kinase, T4 DNA ligase, calf intestinal 
phosphatase
Roche: BamYil, EcoKV
2.1.3 Antibodies
Antibodies were supplied by the following:
Sigma Chemical Company Goat anti-mouse IgG-HRP conjugate, Goat 
anti-mouse IgG-FITC conjugate, Goat anti­
mouse IgG-Cy5 conjugate, Goat anti-rabbit 
IgG-HRP conjugate
Dr Susan Graham, MRC Virology Unit Ab726 (Polyclonal anti-peptide antibody
made against C-terminus of pORF6)
2.1.4 Radiochemicals
y-32P-ATP and 35S-Methionine and were supplied by NEN.
2.1.5 Plasmids
Plasmid pACLL29.1 was described previously (Livingston and Jones, 1989). Cos 86 
was obtained from Dr Andrew Davison, MRC Virology Unit, Glasgow.
Dr Terry McDonald Made the peptide corresponding to the C- 
terminus of pORF6 used to make Ab726.
2.1.6 Oligonucleotides
Oligonucleotides used for PCR amplification and sequencing of ORF6 were obtained 
from MWG-Biotech AG.
Oligonucletotides used for EMSAs were obtained from Sigma-Genosys.
2.2 Miscellaneous materials
Other materials used in experimental work were obtained from the following;
Amersham Pharmacia Biotech Nitrocellulose membrane
Medicell International Ltd Dialysis membrane
Dynex Technologies Inc, USA Immulon 1 microtitre plates
Whatman International Ltd 3MM filter paper, anion exchange paper
Kodak Ltd X-omat film
UKC Chemical Laboratories Citifluor

AE buffer
100 mM Tris-HCl (pH 8), 100 mM NaCl, 2 mM 
EDTA, 0.5% (v/v) deoxycholate, 1% (v/v) NP40, 
10% (v/v) glycerol, 1 complete protease inhibitor 
tablet per 50 ml
Cell Fix solution -20°C acetone/methanol (1:2) solution
Cell freezing Mix Appropriate cell medium + 10% DMSO
Cell Permeabilisation Solution
19 ml PBS, 1 ml 10% NP40, 2 g sucrose
Coomassie blue gel stain
5% (v/v) methanol, 7% (v/v) acetic acid, 0.2 % 
Coomassie brilliant blue
DNA loading buffer (5x) 4% sucrose, 0.25% bromophenol blue, 0.25% xylene cyanol
ELISA washing buffer (lOx) 1.45 M NaCl, 75 mM Na2H P04, 28 mM NaH2P 0 4, 0.5% (v/v) Tween-20
Gel destain
5% (v/v) methanol, 7% (v/v) acetic acid, 88% (v/v) 
water
IP wash
100 mM Tris-HCl (pH 8), 100 mM NaCl, 2 mM 
EDTA
PBS
170 mM NaCl, 3.4 mM KC1, 10 mM Na2HP04, 1.8 
mM KH2P 0 4, 6.8 mM CaCl2, 4.9 mM MgCl2 (pH 
7.2)
PBS-Tween
PBS with 0.001% Tween-20
Resolving gel buffer 0.74 M Tris-HCl (pH 8.0), 1% SDS
SDS-PAGE sample buffer 6% SDS, 30% stacking gel buffer, 30% glycerol, 
210 mM P-mercaptoethanol, 0.3% bromophenol 
blue
SDS-PAGE tank buffer 52 mM Tris, 53 mM glycine, 0.1% SDS
Stacking gel buffer 0.122 M Tris-HCl (pH 6.7), 0.1% SDS
TAE 40 mM Tris-acetate, 1 mM EDTA
TBS 20 mM Tris-HCl (pH 7.5), 500 mM NaCl
Towbin transfer buffer
25 mM Tris base, 192 mM glycine, 20% methanol 
(v/v), 0.01% SDS (w/v)
2.4 Cells and cell culture
2.4.1 Bacterial cells and culture
E. coli strain DH5a was used for the maintenance and propogation of plasmid DNA. 
Bacterial cells were grown in LB. Agar plates were made using 1.5 % (w/v) agar in LB. 
When necessary, media and agar plates were supplemented with the appropriate 
antibiotics.
2.4.2 Eukaryotic cells
All cell media and supplements were obtained from Gibco, BRL. The following cell 
lines were used in experimental work. The S f  cells were obtained from the cytology 
department in the Institute of Virology. The B cell lines were obtained from Dr David 
Blackboum from the Institute of Virology.
Spodoptera frugiperda-2\ (Sf) Insect cell line derived from worm ovarian tissue
(Vaughn et al., 1977).
BCBL1 B cell line latently infected with KSHV established
from a human primary effusion lymphoma (Drexler 
etal., 1999).
BJAB EBV negative B-lymphoma cell line. (Source: 
American type culture collection)
2.5 Cell Culture
2.5.1 Insect cell culture
S f  cells were grown in 175cm2 plastic flasks containing 50 ml TC-100 medium 
supplemented with 5% FCS, 1% penicillin-streptomycin and incubated at 28°C without 
C 02. Cells were passaged by removing the existing medium then shaking the cells into a 
small amount of fresh S f  medium added to the vessel. Harvested cells were typically 
split 1:4 into fresh flasks.
2.5.2 B-cell culture
B cells were grown in 80 cm plastic flasks containing 20ml RPMI medium 
supplemented with 10% FCS, 1% L-glutamine, 1% non-essential amino acids, 1% 
neomycin. Cells were passaged every 5 days by diluting with fresh medium, typically 
1:4, and transferred into fresh flasks.
2.5.3 Hybridoma cell culture
Hybridoma cells were cultured in 96 well plates in Dulbecco’s medium supplemented 
with HAT (0.1 mM sodium hypoxanthine, 0.4 pM aminopterin, 0.01 mM thymidine), 
10% FCS, 1% L-glutamine, 1% penicillin-streptomycin. On the appearance of a single 
colony the cells were transferred into 24 well plates. Cells were subsequently cultured
9 9into 25cm flasks and then 80cm flasks.
2.6 DNA Manipulation
2.6.1 PCR amplification of ORF6
PCR amplification was performed on an Eppendorf Mastercycler PCR machine. 
Reaction mixtures were subjected to an initial denaturation step of 95°C for 5 minutes, 
then allowed to cycle 30 times through the following sequence of temperatures; 1) 
template denaturation at 95 °C for 1 minute, 2) primer annealing at 55°C for 1 minute, 3) 
DNA polymerisation for 4 minutes at 72°C. Specimens were then held at 4°C.
Reaction mixtures contained primers (lOOng), 10 x vent buffer, lOmM dNTP mix, vent 
DNA polymerase (10 units), cos 86 (lOOng) (cosmid containing pORF6 gene) in 50 pi.
The primers used to amplify the ORF6 gene from Cos 86 were:
5 ’-GGCCCGGATCCATGGCGCTAAAGGGCACACAAA-3 ’ (forward)
5 ’-GGCCCGGAICCCTACAAATCCAGGTCAGAGAGC-3 ’ (reverse)
The stop and start codons are shown in red and the BamRl sites are underlined.
2.6.2 Restriction enzyme digestion of DNA
Restriction enzyme digestions were carried out using commercial enzymes and 
corresponding buffers. Typically, 0.5-2 pg of DNA was digested in a final volume of 10- 
20 pi using an excess of enzyme (5-10 units/digest) and the corresponding buffer at the 
recommended temperature for 1-2 hours.
2.6.3 Agarose gel electrophoresis of DNA
DNA samples were mixed with a 1/5 volume of DNA loading buffer and loaded into 
wells in horizontal 1% agarose gels made in lx  TAE containing 0.5 pg/ml EtBr. 
Electrophoresis was carried out using Bio-Rad sub-cell DNA gel electrophoresis systems 
with the gel submerged in lx  TAE also containing EtBr for approximately 40 minutes at 
70 V. DNA was visualised using either a short wave or long wave UV transilluminator, 
as appropriate.
2.6.4 Purification of DNA from non-denaturing agarose gels
DNA fragments resolved by agarose gel electrophoresis were visualised under long-wave 
UV illumination and the required bands were cut from the gel. The DNA was purified 
using the Geneclean kit by Bio 101 Inc., according to the manufacturer’s instructions and 
using supplied materials. The volume of the gel slices was determined and 3x volumes 
of Nal were added. The gel was melted by incubating at 45°C for 5-10 minutes. A 10 pi 
volume of DNA-binding glassmilk was added and the solution was incubated at room 
temperature, with mixing, for approximately 15 minutes. The glassmilk was pelleted at 
13 000 rpm for 5 secs and washed using 400 pi of wash solution. This wash was repeated 
twice. After the final wash, tubes were left open at room temperature for 10 minutes to 
ensure ethanol from the wash solution had evaporated. The DNA was re-suspended in 
dH20 , approximately 20 pi for ~ 5 pg of DNA.
2.6.5 DNA ligation reactions
Ligation of DNA fragments and linearised plasmid DNA was carried out as follows. 
Fragment and plasmid DNA were mixed such that the fragment or insert DNA was in 
molar excess over the plasmid DNA by approximately 3-fold. One unit of bacteriophage 
T4 DNA ligase enzyme was added along with an appropriate amount of 10X ligase 
enzyme buffer in a final volume of 20 pi. Reactions were incubated overnight at room 
temperature. The plasmid was subjected to treatment using calf intestinal phosphatase 
(CIP) enzyme prior to the ligation, in order to prevent recircularisation during the ligation 
reaction. Typically, 10 units of CIP along with phosphatase buffer was added to 1 pg of
restriction enzyme-digested plasmid DNA in a final volume of 20 pi and incubated at 
37°C for one hour.
2.6.6 Preparation of competent DH5a E. coli cells
A single colony of DH5a E. coli cells was used to inoculate 5ml of LB and grown 
overnight at 37°C in an orbital shaker. The next day, 1 ml of the overnight culture was 
diluted in 50 ml LB and allowed to grow for 2 hours at 37°C, with shaking. Cells were 
chilled on ice for 20 minutes and then pelleted at 3000 rpm (microfuge) for 5 minutes at 
4°C. The pellet was resuspended in 25 ml 0.1 M CaCl2 and incubated on ice for 30 
minutes. The cells were pelleted again at 3000 rpm (microfiige) for 5 minutes at 4°C and 
finally resuspended in 4 ml 0.1 M CaCl2. Cells were stored at 4°C for at least one hour 
before use in transformation reactions.
2.6.7 Transformation of competent DH5a E.coli cells
Approximately 100 ng of DNA (either unmodified plasmid DNA or that from ligation 
reactions) was mixed with 200 pi of competent cells and incubated on ice for 30 minutes. 
Competent cell/DNA mixtures were then subjected to “heat-shock” by incubating at 
42°C for 90 seconds. 800 pi of LB was added immediately and samples were incubated 
at 37°C for 1 hour, with shaking. Cells were then pelleted at 13000 rpm in a microfiige 
for 30 seconds and 800 pi of the supernatant discarded. The cell pellet was resuspended 
in the remaining 200 pi of medium and then spread onto LB agar plates, containing
ampicillin (50 pg/ ml) using a sterile plastic spreader. Plates were incubated overnight at 
37°C.
In the case of cells transformed using DNA from ligation reactions, individual bacterial 
colonies that had grown were picked from agar plates into 5 ml of sterile LB containing 
the appropriate antibiotic (to which the transformed plasmid confers resistance) and 
shaken overnight at 37°C. The following day, small-scale preparations of plasmid DNA 
were made.
2.6.8 Small scale preparation of plasmid DNA (mini-prep)
Bacteria contained in 10 ml of overnight culture were pelleted by centrifugation at 13000 
rpm (microfuge) for 30 seconds and the supernatant discarded. Plasmid DNA was then 
isolated using a ‘Perfect Prep’ kit (5’->3’, Inc) according to the manufacturers 
instructions and using reagents as supplied. Plasmid DNA was eluted from the column 
using 60 pi of dH20  at 65°C, and stored at -20°C.
2.6.9 Large-scale preparation of plasmid DNA (maxi-prep)
A single colony of bacteria was used to inoculate 100 ml of LB containing the 
appropriate antibiotic, using a sterile loop. Cultures were grown in 500 ml flasks. The 
cells were pelleted by centrifugation at 3000 rpm for 15 minutes and the supernatant was 
discarded. The DNA was extracted using a Qiagen maxi-prep kit following the 
manufacturers instructions.
2.6.10 DNA sequencing
An ABI automated sequencer was used for sequencing of double-stranded recombinant 
plasmid DNA, using the dideoxy method of Sanger, (1977). Sequencing was carried out 
by Aidan Dolan. Alignment of the DNA sequence was carried out using Gap4 (Staden et 
al., 1998).
2.7 Analysis of Proteins
2.7.1 SDS-PAGE
Complex protein mixtures were resolved using SDS-PAGE. The Bio-Rad Mini Protean 
II gel apparatus was used to prepare and run mini gels. Usually 10 % polyacrylamide 
resolving gels (acrylamide:bisacrylamide 37.5:1) were prepared in lx running gel buffer 
and poured between vertical mini-gel plates. A 7.5% polyacrylamide stacking gel 
(acrylamide:bisacrylamide 19:1) prepared in lx stacking gel buffer was polymerised on 
top of the resolving gel. Prior to loading into gel wells, protein samples were mixed with 
1/3 volume of SDS-PAGE sample buffer and boiled for 5 minutes. Gels were 
electrophoresed at 180 mA for 40-60 minutes, until the dye front reached the bottom of 
the gel. Proteins were detected by staining gels in 0.2 % Coomassie blue stain for 10 
minutes followed by de-staining or transferred onto nitrocellulose membrane by western 
blotting for detection using antibodies.
2.7.2 Western Blotting
Proteins were transferred from polyacrylamide gels onto nitrocellulose membranes 
according to the method of Towbin et al. (1979). Gels were placed on top of Whatman 3 
MM paper presoaked in Towbin transfer buffer. A sheet of nitrocellulose membrane 
followed by another sheet of 3 mm paper (both pre-soaked) were placed on top of the 
gel. This assembly was transferred into a Bio-Rad mini trans-blot cartridge and tank as 
instructed. Electro-blotting was carried out in Towbin transfer buffer for 1 hour at 200 
mA.
2.7.3 Detection of proteins on nitrocellulose membrane using antibodies
Nitrocellulose membranes were immersed in blocking buffer, consisting of 5% dried 
milk in PBS, and agitated for 1 hour at room temperature or overnight at 4°C. Blocking 
buffer was rinsed off using PBS containing 0.001% Tween-20 (PBS-Tween) and then the 
membranes were incubated with primary antibody, either in sealed plastic bags or 
suitable plastic containers, at room temperature for 1-2 hours. After three 5 minute 
washes in PBS-Tween, the membranes were incubated with either anti-mouse or anti­
rabbit IgG horseradish peroxidase-conjugate antibody (depending on the source of 
primary antibody), diluted 1:1000 in PBS-Tween, at room temperature for 1 hour, with 
agitation. Unbound secondary antibody was removed by three 5 minute washes using 
PBS-Tween. Membranes were then transferred onto glass plates and treated using 
Amersham ECL western blotting reagents according to the manufacturer’s instructions. 
After incubation, the nitrocellulose was covered with transparent film and then exposed 
to Kodak X-Omat film, which was processed using a Konica 101 SRA film developer.
2.7.4 Quantification of proteins
Protein concentrations were determined using the Bio-Rad protein assay kit (micro­
assay), which is based on the Bradford dye-binding protein assay (Bradford, 1976), 
according to the manufacturers instructions. A standard curve of protein concentration 
against absorbance at 595 nm was produced, using BSA as the standard protein at the 
following concentrations (pg/ml); 50,100, 200, 400, 800 and 1000. The absorbance of 
the sample proteins was measured and protein concentration calculated from the standard 
curve. OD was read at 280 nM.
2.8 Generation of recombinant Baculovirus
2.8.1 Transfection
The recombinant baculovirus was made using a BacPAK kit (Clontech). S f  cells were set 
up in 35ml dishes at of lxlO6 cells/plate (2 mis) and were incubated at 28°C overnight. 
The following day two tubes were prepared containing: tube 1) 0.5 pg of viral DNA 
(linearised baculovirus DNA) and 2 pg of plasmid DNA (pIDl), made up to a volume of 
500 pi with TC100 without supplements; tube 2) 15 pi of lipofectin and 485 pi of TC100 
(without supplements). The contents of the two tubes were mixed together and incubated 
at room temperature for 15 minutes. The growth media from the 35 ml dishes was 
removed and the cells were washed twice with TCI 00 without supplements. 1 ml of the 
DNA/liposome mix was then added to the plates, which were incubated for 4 hours at 
28°C. The cells were washed with TCI 00 (complete). 2mls of TCI 00 (complete) was 
then added to the dishes, which were subsequently incubated for 3 days at 28°C.
2.8.2 Screening progeny from transfection (Plaque assay)
S f  cell monolayers set up in 35ml dishes at lxlO6 cells/plate (2 mis) were incubated at 
28°C overnight. The transfected cells (see above) were harvested with their media and 
were placed into bijoux bottles and sonicated. Serial 10-fold dilutions were prepared in 
TCI00 without supplements. These were neat, 10'1, 10'2, 10'3 and KT4. The medium 
from the S f  cells set up the day before was removed and 200pl of the diluted virus was 
added. This was adsorbed for 1 hour at room temperature. The inoculum was then 
removed and 2mls of 3% LGT agar diluted 1:1 with complete TCI00 was added. Once 
set, 1ml of complete TCI00 was added. The plates were then incubated for 3-5 days 
until plaques had formed.
2.8.3 Picking plaques
The medium left on the agarose was removed and 1ml of neutral red diluted 1/25 with 
complete TCI00 was added. The plates were incubated at 28°C for 3 hours. Next the 
neutral red was removed and the clear plaques were picked using sterile yellow tips and 
placed into 500pl of complete TCI00 in bijoux bottles. The agar plug was pipetted out 
of the tip and was then vortexed thoroughly. Half of this solution was frozen at -70°C 
and the other half was used to inoculate a cell suspension containing 5xl05 S f  cells in 1 
ml of medium per well in a 24 well plate. As controls two of the wells were left 
uninoculated. The cells were incubated for 4 days at 28°C and were then checked for 
CPE compared to the control cells.
2.8.4 Screening for recombinants expressing ORF6 protein 
Wetern blot
The cells and media were harvested from each well into eppendorf tubes and were spun 
at 13000 rpm (microfuge) for 5 minutes. The supernatant was removed and stored in an 
eppendorf tube at -70°C. The cell pellet was washed twice with PBS with intervening 2 
minute spins at 13000 rpm. It was then resuspended in 30 pi of SDS-PAGE sample 
buffer. This was run on a SDS-PAGE minigel and a western blot performed to determine 
which samples were positive for the ORF6 protein. The blot was probed with polyclonal 
antibody Ab726 which had been made against the very C-terminus of the ORF6 protein.
35S-methionine labelling
24-well dishes were seeded with 1x10 6 S f  cells/well in 1 ml medium. At approximately 
70% confluency, they were infected with 100 pi of virus from the picked plaques, or 
parental PAK6 baculovirus at a MOI of 10. Virus was adsorbed for 1 hour at 28°C, then 
fresh medium was added and the cells were incubated at 28°C overnight. The next day, 
the medium was replaced with 500 pi of methionine-free S f  cell medium containing 30 
pCi per well of S-methionine. Cells were incubated at 28°C overnight. The medium 
was removed and the cells were harvested in 500 pi of cold TBS and then pelleted by 
centrifugation at 6000 rpm (microfuge). The supernatant was discarded and the cells 
were washed twice more in 500pl TBS. The cells were centrifuged again at low speed, 
the supernatant was removed and the pellet was resuspended in SDS-PAGE sample 
buffer, boiled for 5 minutes and analysed by SDS-PAGE. The gel was exposed to Kodak 
X-Omat film, which was processed using a Konica 101 SRA film developer.
2.8.5 Preparation of stocks of AcNPV-ORF6
Large scale stocks of baculovirus AcNPV-ORF6 expressing pORF6 were generated. 
60mm dishes were seeded with 2.5x106 s f  cells in 5mls of complete TCI 00. The 
following day the media was removed and the cells were infected with 300 pi of the 
supernatant that had previously been stored at -70°C (2.8.4). This was adsorbed for 1 
hour then 2 mis of complete TCI00 was added and the plates were incubated at 28°C for 
4 days. The cells and media were then harvested and sonicated. Large flasks were set up 
with S f  cells. When the cells were -70% confluent they were infected with 1ml of the 
virus from the 60 mm dishes. This was adsorbed for 1 hour then 20 mis of TCI 00 was 
added and the cells were incubated at 28°C for 3 days. The cells and media from the 
flasks were then harvested and stored in bijoux bottles at -70°C. This was the original 
stock. An elite stock was made from this using the same method but using 5 flasks for 
and then a working stock was made from the elite stock also using 5 flasks. The working 
stock was concentrated by pelleting the virus from the supernatant at 12 000 rpm at 4°C 
in a Sorvall SLA1500 rotor for 2 hours. The pellet was resuspended in 3mls of complete 
media and stored at -70°C. Virus was titrated by a plaque assay, as described in section 
2 .8 .2 .
2.8.6 Sterility of viral stocks
The sterility of viral stocks was checked by streaking samples onto blood agar plates.
The plates were incubated at 31°C for up to 5 days and any viral stocks containing 
bacterial contamination were discarded.
2.9 Purification of ORF6 protein
2.9.1 Infection of S f  cells with baculovirus AcNPV-ORF6
n
Typically, 10 large flasks of S f  cells at approximately 70% confluency (3.5x10 cells/ 
flask) were infected with recombinant baculovirus AcNPV-ORF6 at a MOI of 10. Virus 
was adsorbed for 1 hour, and then 20 ml medium was added to the flasks, which were 
then incubated for 48hrs at 28°C.
2.9.2 Harvesting of infected Sf cells and extraction of protein
Cells from the flasks were harvested into the existing cell medium by shaking and 
transferred to Falcon 225 ml conical centrifuge bottles. The cells were pelleted by 
centrifugation at 3000 rpm for 7 minutes at 4°C (Sorvall RT-7 Benchtop centrifuge) and 
the supernatant discarded. The pellet was washed 3 times by resuspension in 80 ml ice- 
cold TBS followed by centrifugation at 3000 rpm for 7 minutes at 4°C, each time the 
supernatant being discarded. The cells were kept on ice throughout this procedure. 
Following the final wash, cell pellets were resuspended in 10 mis of extraction buffer (20 
mM Hepes (pH7.6), 0.5 mM DTT, 0.5 mM MgCl2, 10 mM NaHSCb, 1 protease inhibitor 
tablet per 50 ml) then transferred to a dounce homogeniser. The cells were lysed by 10 
strokes in the homogeniser and pelleted at 4000 rpm and the supernatant discarded. The 
pellet was resuspened in 10 mis of high NaCl extraction buffer (20 mM Hepes (pH7.6),
3.4 M NaCl, 0.5 mM DTT, 0.5 mM MgCl2, 10 mM NaHSC>3, 1 protease inhibitor tablet 
per 50mls) and incubated on ice for 10 minutes. The lysed cell suspension was 
transferred to Sorvall 35 ml centrifuge tubes and centrifuged at 40000 rpm for 1 hour at 
4°C in a Sorvall T865 ultracentrifuge rotor. The final supernatant was carefully decanted 
and kept on ice.
2.9.3 Ion exchange chromatography
All chromatography was carried out using the AKTA 900 purification system. 
pORF6 was purified from the insect cell lysate by a two-step chromatography process. 
The first column was a heparin sulphate column (5 ml). Heparin sulphate is a high 
capacity cation exchanger. The column was firstly equilibrated with hepes buffer (20 
mM hepes (pH 7.6), 0.5 mM DTT, 0.5 mM EDTA, 100 mM NaCl, 10% glycerol). 
Clarified cell extract that had been dialysed overnight against hepes buffer, was loaded 
onto the column at a flow rate of 2 ml/minute. The column was washed with 5 column 
volumes of hepes buffer. Finally a 0-1M NaCl gradient in hepes buffer was applied over 
20 column volumes at a flow of 5 ml/minute. Fractions of 1ml were collected, 50 pi was 
taken from each fraction for use in subsequent analysis and the remainder was kept at 
4°C.
Fractions eluted from the column were analysed by SDS-PAGE and staining with 
Coomassie blue. Fractions containing pORF6 were pooled and dialysed overnight 
against Tris buffer (see below).
The second column was a monoQ column (1 ml), which is a strong anion exchanger.
The column was firstly equilibrated with Tris buffer (20 mM Tris-HCl (pH8), 0.5 mM 
DTT, 0.5 mM EDTA, 100 mM NaCl, 10% glycerol). The pooled and dialysed fractions 
from the previous column were loaded onto the column. The column was washed with 5 
column volumes of Tris buffer. A 0-1M NaCl gradient in Tris buffer was applied over 
50 column volumes at a flow rate of 1 ml/minute. Fractions of 1ml were collected and 
analysed on a Coomassie blue stained SDS-PAGE gel. Peak fractions were aliquoted 
into 50 pi volumes and frozen at -70°C.
2.9.4 Gel filration chromatography of pORF6
A 24 ml superose column 12 HR 10/30 (Amersham) was used to determine the size of 
pORF6 in solution. Tris running buffer (20 mM Tris-HCl (pH8), 0.5 mM DTT, 0.5 mM 
EDTA, 100 mM NaCl, 10% glycerol) was used at a flow rate of 0.2 ml/min. 200pl of 
Blue dextran, Aldolase and BSA each at a concentration of 1 mg/ml were firstly loaded 
onto the column, as molecular markers. These were eluted with 1.5 column volumes and 
a second identical run was started using 200 pi of pORF6 (2 mg/ml). 0.5 ml fractions 
were collected and analysed by western blot for the presence of pORF6.
2.10 Purification of MAb52
A protein G column (5 ml) was used to purify MAb52. The MAb52 supernatant was 
dialysed overnight in a 20 mM sodium phosphate buffer (pH 7). The column was 
equilibrated with the same buffer. The dialysed supernatant was applied to the column. 
Any unbound protein was washed out with 5 column volumes of running buffer. Bound 
protein was eluted with a 0.1M glycine buffer (pH 2.7) over 5 column volumes. The 0.5 
ml fractions were eluted into eppendorfs containing 40 pi 1M Tris (pH 9) to neutralise 
the solution.
2.11.Generation of ORF6-specific MAbs
2.11.1 Preparation of immunogen
Protein pORF6 was purified from insect cell lysate by two-column chromatography as 
described in section 2.9.3. Protein of at least 95% purity was used for immunisation.
2.11.2 Immunisation schedule
Female Balb/c mice were immunised subcutaneously initially using 20pg of soluble 
pORF6 emulsified in Freund’s complete adjuvant. This was followed by three booster 
injections of 20 pg pORF6 emulsified in Freund’s incomplete adjuvant, at two week 
intervals. Sera from test bleeds were titrated against pORF6 in ELISA to ascertain which 
animals exhibited the best antibody response. In preparation for the fusion, the 2 best- 
responding mice were given final intra-peritoneal boosts of 60 pg pORF6 emulsified in 
Freund’s incomplete adjuvant.
2.11.3 Preparation of spleen cells for fusion
Mice were killed by cervical dislocation and the spleens removed immediately and 
placed in sterile DMEM medium on ice. Spleen cells were isolated by puncturing the 
spleen surface several times with a 26-G needle and injecting sterile medium into the 
spleen using another 26-G needle and syringe, forcing cells out through the perforations. 
The extracted cells were pelleted at 1400 rpm (Sorvall RTH-250 rotor) for 10 minutes at 
4°C , the supernatant was removed and 10ml of sterile DMEM was used to resuspend the 
cells, which were then counted.
2.11.4 Preparation of Myeloma Cells
Confluent Sp2/0-Agl4 cells were harvested by shaking into their existing medium and 
then pelleted at 1400 rpm (Sorvall RTH-250 rotor) for 10 minutes at 4°C. The cell pellet 
was stored on ice. Some of the supernatant was retained for use in the conditioned 
medium to be added subsequently to the cells following fusion.
2.11.5 Fusion protocol
1 x 107 myeloma cells and 1 x 108 spleen cells, were mixed in a 50 ml tube and pelleted 
at 1400 rpm (Sorvall RTH-250 rotor) for 5 minutes. The supernatant was removed and 
the cell pellet tapped loose. Fusion of the splenocytes and myeloma cells was achieved 
by adding 1 ml of 50% PEG (1 ml of PEG mixed with 1 ml of DMEM at 37°C) to the 
cells and mixing gently. After 1 minute, the PEG was diluted 1:2 using 1 ml of DMEM. 
Dilution of the PEG was repeated by adding a further 4, 8 and 16 ml DMEM at 2, 3 and 4 
minutes respectively. The cells were then centrifuged at 1400 rpm (Sorvall RTH-250 
rotor) for 15 minutes and resuspended in conditioned HAT medium, comprising 75% 
fresh HAT medium and 25% pre-conditioned Sp2/0-Agl4 cell medium (medium in 
which Sp-2 cells had previously been grown) at a final concentration of 107 Sp2/0-Agl4 
cells per 100 ml. The cell suspension was distributed into 96 well microtitre plates by 
adding 150 pi per well, and incubated at 37°C in a humidified incubator with 5% C 02.
2.11.6 HAT selection and maintenance of fused myeloma/spleen cells
The cells were checked after 3 days to ensure the HAT medium was killing the Sp2/0- 
Agl4 cells. At 7-10 days following the fusion, the wells were monitored for the 
appearance of large colonies of hybrid myeloma/spleen cells. The supernatant from 
wells containing single colonies of diameter approximately one third of the well was 
screened for reactivity against ORF6 by ELISA, as described below.
2.11.7 ELISA screening of hybridoma cell supernatant
Immulon 1 microtitre plates were coated with 200 ng/well of purified pORF6 diluted in 
PBS at 37°C overnight, then blocked using 2% BSA in PBS (100 pl/well) for 1 hour at 
37°C. Hybridoma cell supernatant (50 pi) was added to the wells and incubated at 37°C
for one hour. The plates were washed 6x in PBS + 0.005% Tween 20 and were tapped 
dry before adding 50 pl/well of anti-mouse-HRP conjugate secondary antibody and 
incubating at room temperature for 1 hour. Unbound conjugate was removed by washing 
6x using PBS/Tween-20 and the plates tapped dry. 100 pi per well of ABTS-peroxidase 
substrate was added and the colour change in each well after twenty minutes was 
measured by reading the optical density at 405 nm. pORF6-reactive supernatant was 
designated as that producing a reading more than twice that produced by control 
supernatant from Sp-2 cells.
2.11.8 Propagation of positive-secreting hybridoma cell lines
Cells secreting positive antibody were transferred to small flasks and topped up with 
fresh HAT medium. Once the cells had reached confluency in the small flasks, the 
supernatant was tested again for reactivity against ORF6 to ensure they were still 
secreting ORF6-reactive antibodies. If positive for anti-ORF6 antibody, cells were 
harvested and transferred to medium flasks and, ultimately, large flasks. Once cells were 
confluent in large flasks, the supernatant medium was collected and frozen in aliquots at 
-20°C. The hybridoma cells were aliquoted in HAT medium containing 10% DMSO and 
frozen down for long-term storage in liquid nitrogen.
2.12 Testing of MAbs
2.12.1 Testing reactivity of MAbs against ORF6 in western blotting
Cell extracts from S f  cells infected with the recombinant baculovirus AcNPV-ORF6 or 
PAK6 baculovirus were used. The cell extracts were subjected to SDS-PAGE and 
transferred to nitrocellulose as described in section 2.7.2. The nitrocellulose membranes
were cut into 0.5 mm strips and incubated in blocking buffer overnight at 4°C.
Individual strips were incubated with 1 ml of a single hybridoma cell supernatant at room 
temperature for 1 hour. The remainder of the western blot was carried out as described 
in 2.7.3.
Cell extracts from B cells infected with KSHV were also used. Cells were induced by 
adding sodium butyrate (1 mM). At various times after induction the cells were pelleted 
in a microfuge at 6000 rpm for 5 minutes and lysed in a cell lysis buffer (100 mM Tris- 
HCl, 100 mM NaCl, 2 mM EDTA, 2 mM EGTA, 1% NP40, 0.5% sodium deoxycholate, 
0.5 mM PMSF). The cell extracts were used in a western blot as described in sections 
2.7.1-2.7.3.
2.12.2 Testing reactivity of MAbs to ORF6 in immunofluorescence
S f  cells were set up in 35 ml dishes at lxlO6 cells/ml (2 ml) and were incubated at 28°C 
overnight. The next day, the medium was removed and the cells were infected with 
recombinant baculovirus AcNPV-ORF6 or PAK6 baculovirus at a MOI of 10 and 
incubation continued at 28°C. After 48 hours, the cells were washed 3 times using PBS- 
Tween. The cells were then resuspended in PBS and placed onto a slide using a cytospin 
(800 rpm for 3 min) and fixed by soaking in -20°C acetone/methanol (1:2) solution at 
-20°C for 20 minutes. After a further 3 washes with PBS-Tween, blocking solution (1% 
FCS in PBS-Tween) was added and left at 37°C for 1 hour. This solution was removed 
and 400 pi of undiluted supernatant medium from monoclonal hybridoma cells was 
added. After 1 hour at 37°C, the cells were washed 3 times using PBS-Tween (1%). A 
1:200 dilution of a-mouse-FITC conjugate was added to the cells (150 pi) and incubated 
at RT for 1 hour. The cells were again washed 3 times using PBS-Tween. Coverslips 
were mounted onto a small drop of Citifluor solution (UKC), covering the cells.
Examination of immunolabelled cells was performed using a Zeiss LSM 510 confocal 
microscope attached to a computer operating the appropriate LSM 510 software.
Immunofluorescence of B cells infected with KSHV was carried out using a similar 
method except the cells were placed onto the microscope slide by pelleting the cells (2ml 
at 7xl05/ml), resuspending in 20 pi of PBS and spotting onto the slide which was then air 
dried.
2.12.3 Screening MAbs for reactivity against pORF6 by immunoprecipitation: 
expression of radiolabelled pORF6 protein
24-well dishes were seeded with 1x10 6 S f  cells/well in 1 ml medium. At approximately 
70% confluency, they were infected with AcNPV-ORF6 or PAK6 baculovirus at a MOI 
of 10. Virus was adsorbed for 1 hour at 28°C, then fresh medium was added and the 
cells were incubated at 28°C overnight. The next day, the medium was replaced with 
500 pi of methionine-free S f  cell medium containing 30 pCi per well of S-methionine. 
Cells were incubated at 28°C overnight. The medium was removed and the cells were 
harvested in 500 pi of cold TBS and pelleted by centrifugation at 6000 rpm (microfuge). 
The supernatant was discarded and the cells were washed twice more in 500 pi TBS.
The cells were centrifuged again at low speed, the supernatant was removed and the 
pellet was kept on ice. Proteins were extracted by resuspending the cell pellet in 150 pi 
of cold AE buffer and incubating on ice for 20 minutes. Extracts were then centrifuged 
at 35000 rpm for 30 minutes at 4°C in a Beckman TLA-100.2 rotor (Beckman TLA-100 
benchtop ultracentrifuge). Small samples of the supernatant containing extracted 
proteins from AcNPV-ORF6 and PAK6-infected cells were analysed by SDS-PAGE to
check that pORF6 had been expressed. The gel were dried and exposed to a 
phosphorimage screen.
2.12.4 Immunoprecipitation of pORF6 from insect cell extracts
Proteins were extracted in cold AE buffer as described above. Cell extracts were mixed 
with 100 pi of MAb (undiluted hybridoma cell supernatant) for 2.5 hours at 4°C. 50 pi 
of a 50% suspension of Protein A-sepharose beads in buffer AE was then added and 
mixed for a further 1.5 hours at 4°C. Samples were then centrifuged at 6000 rpm in a 
microfuge for 2 minutes to pellet the protein A sepharose beads and the supernatant was 
discarded. The beads were then washed to remove any proteins not specifically bound. 
The beads were re-suspended in 500 pi of cold AE buffer and centrifuged at 6000 rpm in 
a microfuge for 2 minutes. The supernatant was discarded and the beads were washed 
twice. After the final wash, the pelleted beads were mixed with 50 pi of SDS-PAGE 
sample buffer and boiled for 5 minutes to dissociate the bound proteins. The beads were 
briefly centrifuged again at 6000 rpm and the supernatant was analysed by SDS-PAGE, 
together with a whole insect cell lysate sample to allow identification of the pORF6 
protein band. Following electrophoresis, gels were vacuum dried at 80°C for 1 hour and 
exposed to a phosphorimage screen.
2.13 DNA-Protein binding assay
2.13.1 Preparation of radio labelled DNA
Single stranded DNA (poly dT) was 5’ labelled using T4 bacteriophage polynucleotide 
kinase and y-32P ATP (30 pCi per reaction) in 1 x buffer (70 mM Tri-HCl (pH 7.6), 10 
mM MgCh, 5 mM D TT) in a volume of 30 pi for 30 mins at 37°C. Labelled DNA was 
stored at 4°C.
2.13.2 Electrophoretic Mobility Shift Assay (EMSA)
A 5% non-denaturing polyacrylamide gel (30:1 acrylamide : bisacrylamide) was 
prepared and pre-run for 1 hr at 100-150 V using 0.5x TBE as tank buffer. Binding 
reactions were set up in 1.5 ml eppendorf tubes containing the specified amounts of 
pORF6 and 32P labelled poly dT in 1 x buffer (20 mM tris, 0.5 mM DTT, 0.5 mM EDTA, 
100 mM NaCl, 10% glycerol) in a volume of 30 pi. These were incubated for 30 min at 
37°C. The samples were loaded onto the gel without sample loading buffer.
Bromophenol blue containing sample buffer was loaded onto a separate lane to observe 
how far the gel had run. The gel was run for approximately 4 hours at 100-150 V in a 
4°C room until the dye front was two thirds of the way to the bottom of the gel. The gel 
was then placed onto DE81 anion exchanger chromatography paper (Whatman), which in 
turn was placed onto a sheet of 3MM paper and a sheet of transparent film was placed on 
top of the gel. The gel was vacuum dried at 80°C for 1 hour and then exposed to a 
phosphorimage screen.
The phosphorimages were quantified using the Bio-rad quantity one software. Areas of 
the same size were highlighted around the bands to be quantified and volume analysis 
was carried out to determine the relative counts of radioactivity in the selected regions.
2.14 Surface plasmon resonance
Surface plasmon resonance was performed using the BIAcore 2000 in conjunction with 
chips and buffers supplied by BIAcore. A streptavadin chip, which consisted of four flow 
cells coated with streptavadin was employed. The chip was conditioned by three 1 min 
injections of 1M NaCl in 50 mM NaOH at a flow rate of 20 pl/min. Biotin 5’ end- 
labelled DNA dissolved in buffer (10 mM Hepes pH 7.4, 150 mM NaCl, 3.4 mM EDTA, 
0.005% v/v surfactant P20) was loaded onto the chip to about 100 response units. Two 
injections of 50 pi of free biotin (1 mg/ml) were then flowed over the cell to block any 
free streptavadin sites. One of the flow cells had no DNA loaded onto it, and was used as 
a reference. The 5’ biotin end labelled oligonucleotides used were poly (dT)is and an 
oligodeoxyribonulceotide of 32 nt with the sequence
GAACGCGAAGCGAAGCGTTCGCACTTCGTCCC which was kindly donated by Dr 
Graeme Thompson (MRC Virology Unit, Glasgow).
For all experiments the BIAcore 2000 was run at 37°C. A series of dilutions of pORF6 
were made using the running buffer and were individually flowed across the chip, at a 
flow rate of 70 pl/min. Association and dissociation times were 180 seconds. Both the 
flow cells, with and without DNA were used. In between injections of pORF6, the chip 
was regenerated with injections of 0.5 M NaCl to remove all bound protein.
The data was analysed using the BIAevaluation software.
Chapter 3
Expression and purification of pORF6
3.1 Introduction
The aim of the work described in this section was to express and purify the product of 
KSHV ORF6 (pORF6) for use in subsequent experiments including the generation of 
monoclonal antibodies. The recombinant baculovirus expression system was selected for 
this purpose as it had previously been successfully employed to express the SSBs of 
other human herpesviruses (Boehmer and Lehman, 1993a; Tsurumi et a l , 1998), and it 
has advantages being a eukaryotic expression system. Column chromatography was 
carried out to purify pORF6 to near homogeneity, and was also employed to investigate 
the multimerisation state of the purified pORF6 in solution.
3.2 Construction of a recombinant baculovirus expressing ORF6
To construct the recombinant baculovirus, the ORF6 gene was firstly PCR amplified and 
cloned into the baculovirus transfer vector, pAcCL29.1 (figure 3.1), under the control of 
the strong polyhedrin promoter. PCR amplification of the ORF6 gene was from Cos86 
DNA, a cosmid containing nucleotides 1-7437 of the KSHV genome, which was kindly 
supplied by Dr Andrew Davison (MRC Virology Unit, Glasgow). The primers were 
designed to amplify a 3.4 kbp fragment spanning nucleotides 3210-6611 containing the 
complete ORF6 gene (accession number U93872). BamRl sites were incorporated into 
the primers to facilitate cloning into the transfer vector.
The PCR reaction was performed as described in methods (section 2.6.1) and the 
products digested with BamHI. Plasmid pAcCL29.1 was digested with BamHl in the 
presence of CIP to prevent recircularization during ligation. The digested PCR product 
and linearized pAcCL29.1 were run on an agarose gel (figure 3.2). The bands were 
excised and the DNA purified as described (section 2.6.4). The gel purified DNAs were
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Figure 3.1 pAcCL29.1 transfer vector and insert
The ORF6 gene was inserted into the Bam HI site. The Bam HI and Eco RV sites on the 
insert are indicated by an arrow. The start codon is indicated with a red line. The Eco RV site 
in the plasmid and the unique site in the ORF6 gene allows orientation of the cloned inserts to 
be determined. AMP represents an ampicillin resistance gene and ORI represents the plasmid 
origin of replication.
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Figure 3.2 plasmid pAcCL29.1 and PCR fragment of ORF6.
T h e  lin e a r ise d  p la sm id  p A c C L 2 9 .1  and th e P C R  fra g m en t c o n ta in in g  th e  a m p lif ie d  O R F 6  
g e n e  w e r e  r e s o lv e d  on  a 1 % a g a r o se  g e l ,  w h ic h  is  s ta in ed  w ith  e th id iu m  b ro m id e . M =  L a m b d a  
D N A - B s t E  II D ig e s t  m ark ers. S iz e s  o f  th e  ap p rop ria te  b a n d s are in d ic a te d  o n  th e  le ft.
ligated and the products were used to transform competent E.coli strain DH5a cells. The 
transformed cells were plated out and ampicillin resistant colonies selected. Twelve 
colonies were picked, grown in 10 ml liquid cultures and small scale plasmid 
preparations were made.
To identify plasmids containing the 3.4 kbp insert, DNA samples were cleaved with 
BamRl and the fragments resolved on an agarose gel alongside RrtEII cleaved 
bacteriophage lambda DNA markers (figure 3.3a). The gel shows DNA from 2 colonies 
which produced two fragments of the sizes expected for the vector and PCR-amplified 
fragment.
Plasmids containing the ORF6 gene in the correct orientation were identified by 
digestion with EcoRV, which cleaves approximately 80 bp upstream of the polyhedron 
promoter and asymmetrically within the ORF6 gene (figure 3.1). Plasmids containing 
the ORF6 gene in the correct orientation should generate fragments of approximately
10.3 kbp and 755 bp, whilst insertion in the opposite orientation would yield fragments 
of approximately 8.2 kbp and 2.5 kbp. Figure 3.3b shows the digest patterns for two 
representative colonies. The fragments generated are consistent with the insert being in 
the wrong orientation in colony 1, but in the correct orientation in colony 2.
A colony containing the insert in the correct orientation (colony 2) was selected, named 
pIDl, and a large scale preparation of DNA made. To confirm that no errors had 
occurred during PCR, the sequence of the entire insert was determined. This sequence 
was identical to the DNA sequence (accession number U93872) except for two 
nucleotide substitutions: a C to T change at position 207, and an A to G change at 
position 1149. These substitutions change codon 68 of the ORF6 gene from AAC to
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Figure 3.3a Analysis of plasmid DNA from transformants
BamHl d ig e s ts  o f  D N A  from  tw o  c o lo n ie s  run a lo n g s id e  la m b d a  D N A  Z?s/EII m o le c u la r  
w e ig h t  m ark ers ( la n e  M ) o n  a 1% a g a r o se  g e l . T h e  ap p rop ria te  m ark er b an d  s iz e s  are 
in d ic a te d  o n  th e  le ft.
Figure 3.3b Digestion of plasmids containing ORF6 insert with E co K \
D N A  from  c o lo n ie s  1 and 2 (sa m e  as f ig u r e  3 .3 a )  c le a v e d  w ith  EcoRV. T h e  fra g m en ts  w e r e  
r e s o lv e d  o n  a 1% a g a ro se  g e l . L an e M  c o n ta in s  la m b d a  D N A  ZfatEII m o le c u la r  w e ig h t  
m ark ers an d  th e  s iz e s  o f  th e  ap p rop ria te  b a n d s  are in d ic a te d  o n  th e  le ft . T h e  7 5 5  bp  fra g m en t  
d ia g n o s t ic  o f  in ser tio n  in  th e co rrect o r ien ta tio n  is  c ir c le d  in  la n e  2 .
A A T , an d  c o d o n  3 8 3  fro m  A C  A  to  A C T , b ut in  e a c h  c a s e  th e  e n c o d e d  a m in o  a c id  
r e m a in s  th e  sa m e  (a sp a r a g in e  and th r eo n in e , r e s p e c t iv e ly ) .
T o  g e n e r a te  th e  re co m b in a n t b a c u lo v ir u s , p la sm id  p I D l  w a s  c o -tr a n s fe c te d  in to  .S/’c e l ls  
w ith  lin e a r iz e d  D N A  o f  th e  b a c u lo v ir u s  P A K 6  (c lo n te c h  B a c P A K  B a c u lo v ir u s  
e x p r e s s io n  sy s te m )  as re c o m m e n d e d  b y  th e  m a n u fa c tu rers. T h e  c e l ls  w e r e  in c u b a te d  fo r  
3 d a y s  at 2 8 °C , p r o g e n y  v ir u s  w e r e  h a rv es te d  an d  titrated  o n  m o n o la y e r s  o f  S / c e l l s .  
P la q u e s  w e r e  p ic k e d  and ex a m in e d  for  e x p r e s s io n  o f  p O R F 6 .
3.3 Recombinant baculovirus AcMNPV-ORF6 expresses the ORF6 protein 
(pORF6)
T o  s e le c t  w h ic h  re co m b in a n t b a c u lo v ir u s  w a s  to  b e  u s e d  fo r  p r o d u c tio n  o f  O R F 6  p r o te in  
(p O R F 6 ) , in d iv id u a l p la q u e  iso la te s  w e r e  first te s te d  fo r  e x p r e s s io n  p O R F 6 . Sf  c e l ls  that  
h a d  b e e n  in fe c te d  w ith  th e  reco m b in a n t b a c u lo v ir u se s  w e r e  la b e lle d  w it h  35S -  
m e th io n in e , fo r  th e  id e n tific a t io n  o f  e x p r e sse d  p r o te in s . T h e  la b e lle d  c e l l  ex tr a c ts  w e r e  
ru n  o n  an  S D S -P A G E  g e l ,  w h ic h  w a s  th e n  e x p o s e d  to  K o d a k  X -O m a t  f ilm , w h ic h  w a s  
su b s e q u e n t ly  d e v e lo p e d  (f ig u re  3 .4 ) .  A s  a c o n tro l Sf  c e l l s  in fe c te d  w ith  th e  p aren ta l 
b a c u lo v ir u s  (P A K 6 )  w e r e  a lso  u sed . T h is  e x p e r im e n t d e m o n str a te d  th a t th e th ree  
re c o m b in a n t b a c u lo v ir u s e s  w e r e  a ll e x p r e s s in g  a  p ro te in , w h ic h  c o r re la ted  w ith  that o f  
th e  p r e d ic te d  s iz e  o f  p O R F 6  (1 2 6  k D a ). I so la te  n u m b e r  n in e  e x p r e s s e d  it m o r e  s tr o n g ly  
th a n  th e  o th e rs .
T h e  p aren ta l b a c u lo v ir u s  a lso  e x p r e sse d  a  p ro te in  o f  a s im ila r  s iz e ,  g a la c to s id a s e  
( 1 1 4  k D a ). T o  c o n fir m  that it w a s  in d e e d  p O R F 6  that h a d  b e e n  e x p r e s s e d  b y  th e  
r e c o m b in a n t b a c u lo v ir u s e s  and n o t a n o th er  p r o te in  o f  a  s im ila r  s iz e ,  a  w e s te r n  b lo t  w a s
pORF6 -►
4 —  9 7 k D a
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Figure 3.4 35S labelling of 5 / c e l l s  infected with recombinant (ORF6) and parental
b a c u lo v ir u s .
S f  cells infected with a recombinant or parental baculovirus were labelled with °S -
methionone. The cells were then boiled for 5 minutes in SDS-PAGE sample buffer and 
resolved by SDS-PAGE. The gel was then exposed to Kodak X-Omat film, which was 
processed using a Konica 101 SRA film developer. Numbers 6, 8 and 9 represent different 
isolates. PAK6 is the parental baculovirus. pORF6 is -126  kDa. The location o f the 97 kDa 
marker is indicated.
p O R F 6
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Figure 3.5 Western blot of cell extract from .S/cells infected with recombinant (ORF6)  
a n d  p a r e n t a l  b a c u lo v ir u s
5 /ce lls  that had been infected w'ith a recombinant baculovirus were boiled for 5 minutes in 
SDS-PAGE sample buffer and resolved by SDS-PAGE. The proteins were transferred onto a 
nitrocellulose membrane and a western blot was carried out using an anti-peptide polyclonal 
antibody (Ab726) made against the very C-terminus o f pORF6. Numbers 6, 8 and 9 represent 
different isolates. PAK6 is the parental baculovirus. pORF6 is 126 kDa. The location o f the 
97 kDa marker is indicated.
carried out using an anti-peptide polyclonal antibody that had been made against the C- 
terminal 15 aa of pORF6 (Ab726) (figure 3.5). Again, S f  cells infected with the parental 
baculovirus were used as a control. This confirmed that all three isolates were 
expressing pORF6 as the antibody reacted against a protein of the correct size and no 
reactivity was seen in the control. A breakdown product of pORF6 was also detected. 
The antibody reacted most strongly against isolate number nine. As this was the 
baculovirus that was expressing pORF6 at the highest level this was chosen for the 
generation of ORF6 protein. Large scale stocks of this virus (named AcNPV-ORF6) 
were produced and titrated for use in subsequent experiments.
3.4 Purification of pORF6
For characterisation of pORF6, purified protein was required. Ten large flasks of S f  cells 
at approximately 70% confluency were infected with the recombinant baculovirus 
(AcNPV-ORF6). After a three day incubation period, the cells were harvested and lysed. 
Column chromatography was employed for the purification. The cell extract was 
dialysed overnight against the column running buffer and applied to the first column, a 
heparin sulphate column. A 0-1M NaCl gradient was run and 1 ml fractions were 
collected. Samples of each fraction were analysed by SDS-PAGE. pORF6 eluted from 
the column at approximately 0.3 M NaCl in seventeen 1 ml fractions corresponding to a 
major peak in the UV absorbance trace (figure 3.6). A stained gel of the peak fractions is 
present in figure 3.7 which shows that pORF6 is the major protein in these fractions.
The peak fractions were pooled and dialysed overnight against the running buffer of the 
second column, a mono-Q column, to which it was applied. A protein peak was 
observed at 0.3M NaCl (figure 3.8) and confirmed as pORF6 by SDS-PAGE. In addition
pORF6
Beady
Figure 3.6 Heparin sulphate column
After being dialysed against the column running buffer the s f  cell extract containing pORF6 
was loaded onto the column. Protein that bound to the column was eluted with a NaCl 
gradient (150m M -lM ). pORF6 was eluted with 0.3M NaCl. The trace shows the UV 
absorbance o f fractions and the position o f the peak o f pORF6 is labelled.
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Figure 3.7 Analysis of pORF6 fractions collected from the heparin sulphate  
column by SDS-PAGE
S/cells were infected with a recombinant baculovirus expressing pORF6. The cell 
extract was applied to a heparin sulphate column and peak fractions were collected. 
These fractions were analysed by SDS-PAGE along with cell extract, purified ICP8 
and markers. The gel was then stained with Coomassie blue.
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Figure 3.8 Mono-Q column
The peak fractions from the heparin sulphate column were pooled and dialysed against the 
column running buffer for this column. They were then loaded onto the column. Protein that 
bound to the column was eluted with a NaCl gradient (150m M -lM ). pORF6 was eluted with 
0.3M NaCl. The trace shows the UV absorbance o f fractions and the position o f the peak o f 
pORF6 is labelled.
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Figure 3.9 Purification of pORF6
pORF6 was purified using a two-step column chromatography method. Samples from each 
stage were resolved on a 10% acrylamide gel and stained with Coomassie blue. M= markers 
(high molecular weight rainbow markers (Amersham)). 1= nuclear extract. 2= Pooled peak 
fractions from heparin sulphate column. 3= Pooled peak fractions from the monoQ column. 
pORF6 is -126 kDa. The 97 kDa marker is indicated.
to further purifying the protein (figure 3.9) this procedure also concentrated it, as the 
protein was eluted in a smaller amount of buffer (3ml).
Figure 3.9 shows an example of the peak fractions containing pORF6 collected from the 
two columns. The fractions from the heparin sulphate column had additional faint bands 
that could be seen on the gel but not on the scanned version. There were no additional 
bands seen after purification with the monoQ column. This demonstrates that the protein 
has been purified to near homogeneity. Several preparations of pORF6 were made 
throughout the project. The concentration of pORF6 was ~2mg/ml, as determined by a 
Bradford assay.
3.5 Confirmation that pORF6 has been purified
To confirm that it was indeed pORF6 that had been purified and not another protein, 
samples of purified pORF6 and ICP8 (HSV-1) (20 pg of each) were western blotted and 
the membrane was reacted with Ab726 (figure 3.10). A strong band of the correct size 
was seen in the lane with purified pORF6, whereas there was no reaction in the lane with 
ICP8. This result indicates that pORF6 was purified successfully and that the purification 
process has removed the breakdown fragments (figure 3.5). It also showed that the 
antibody did not cross-react with ICP8.
Ab726 was made against a branched peptide consisting of the 15 C-terminal amino acids 
of pORF6 (figure 3.11). Figure 3.12 shows this sequence aligned with the 15 C-terminal 
amino acids of ICP8. Although there are a few conserved amino acids and some of the 
amino acids are conserved in their properties, this is not sufficient for a cross reaction of 
Ab726 with HSV-1 ICP8.
pORF6 ICP8
Figure 3.10 Western blot of  purified pORF6
pORF6 that had been purified by column chromatography was resolved by SDS-PAGE (20 
pg). It was then transferred onto nitrocellulose paper and a western blot was carried out using 
an anti-peptide polyclonal antibody made against the very C-terminus o f pORF6. As a control 
purified ICP8 was also used (20 pg).
pORF6 C-terminal sequence
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Figure 3.11 Structure of branched peptide used to generate Ab726
A schematic o f the branched peptide that was used to make Ab726. Four peptides comprising 
o f the C-terminal 15 aa o f  pORF6 are linked together by lysines.
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Figure 3.12 Alignment of pORF6 and ICP8 C-terminus
An alignment o f the C-terminal 15 aa o f pORF6 and ICP8. Identical amino acids are shown in 
red connected with a red line. The amino acids with conserved properties are shown in blue.
3.6 Mass spectrometry of pORF6
For additional conformation that pORF6 had been purified mass spectrometry was 
employed. Mass spectrometry of a tryptic digest of the purified protein was carried out 
by Dr Robin Antrobus (University of St. Andrews). The peptide masses were submitted 
to an on-line search engine (Mascot, Matrix science). It identified the protein as the 
KSHV-ORF6 product, as 37 of the peptides matched to this sequence (figure 3.13). 
Search scores above 74 are considered significant and the search score for KSHV was 
359. This was the only match that scored above 74 confirming that pORF6 had been 
purified.
3.7 Purified pORF6 is monomeric in solution
ICP8 (SSB from HSV-1) has been shown to be monomeric in solution up to 
concentrations of 5mg/ml, by the use of size exclusion chromatography and ultra­
centrifugation (Mapelli et al., 2000). Both T4 gene 32 protein and the adenovirus DBP 
exist as monomers in solution, but only up to a concentration of ~ 0.1 mg/ml (Alberts and 
Frey, 1970; Schechter et al., 1980). Above this concentration, self-association of the 
proteins occurs, creating dimers and sometimes higher molecular weight species, 
depending on the conditions.
To establish whether ORF6 is monomeric in solution, a superose 12 sizing column (24 
ml) was used. The column was first calibrated with proteins of known molecular weight. 
These were aldolase (150kDa) and BSA (67kDa). Blue dextran (2000kDa) was also used 
to mark the exclusion volume of the column, which is 300kDa. Molecules of a greater 
molecular weight than this are eluted at the same point. The aldolase and the BSA were
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Figure 3.13 Peptide matches from the mass spectrometry of purified pORF6
Mass spectrometry o f purified pORF6 was carried out by Dr Robin Antrobus (University o f 
St. Andrews). The peptide masses were submitted to an on-line search engine (Mascot, 
Matrix science). Thirty-seven o f the peptides matched to the ORF6 sequence. These are 
shown in red.
eluted from the column at 12.32ml and 18.98ml, respectively (fig. 3.14). The pORF6 that 
was loaded onto the column was at a concentration of ~ 2mg/ml. The peak of pORF6 
was eluted at 15.01ml, which lies in between the two markers. The peak is asymmetrical 
with a smaller co-joining peak eluting just before the main peak, which is discussed 
below.
To confirm that pORF6 was eluted at this point, fractions were collected and a western 
blot was carried out using Ab726 (figure 3.15). pORF6 has a predicted monomeric 
molecular weight of 126kDa. As it is eluted after the 150Kda marker this suggests that it 
is monomeric in solution. However, the asymmetric shape of the peak suggests there may 
be an equilibrium between monomers and dimers of pORF6, with the monomeric form 
being favoured. There was no evidence of a peak corresponding to a stable dimer of 
pORF6.
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Figure 3.14 Superose 12 column
200 j l x 1 o f pORF6 at a concentration o f ~ 2mg/ml was loaded onto the column. The fractions 
(0.5 ml) were collected and saved. The UV absorbance trace for the pORF6 run is shown. 
The green arrows indicate where the markers were eluted on an identical run. The main peak 
o f pORF6 is indicated.
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Figure 3.15 Western blot against eluted fractions from superpose 12 column.
Peak fractions were collected from the superose 12 column and were resolved by SDS-PAGE. 
The proteins were transferred onto a nitrocellulose membrane and a western blot was carried 
out using an anti-peptide polyclonal antibody that had been made against the very C-terminus 
o f pORF6 (Ab726). The label underneath indicates which fraction is loaded onto the lane. 
pORF6 is 126 kDa. The location o f the 97 kDa marker is indicated.
3.8 Discussion
A recombinant baculovirus was successfully constructed that expresses pORF6 (AcNPV- 
ORF6). After infection of S f  cells with this baculovirus, pORF6 was successfully over­
expressed and purified to near homogeneity, by a two-step chromatography process.
This resulted in pORF6 being produced at a concentration of ~2mg/ml.
The baculovirus system was used to over-express pORF6 as it is a eukaryotic system, 
and therefore post-translational modifications take place. The HSV-1 homologue of 
pORF6, ICP8, has been shown to be phosphorylated and this may also be true for 
pORF6. The purification method that was used was chosen as ICP8 (HSV-1) had been 
purified successfully by similar methods (Bohmer and Lehman, 1993; Dudas and 
Ruyechan, 1998). An advantage of this purification method is that attachment of a tag to 
the protein (e.g. a His tag) is not required. It is not known how the attachment of such 
tags would affect the folding or the function of the purified protein.
An anti-peptide antibody (Ab726) against pORF6 was used to confirm that pORF6 had 
been purified and not another protein of a similar size. This antibody had also been used 
to verify that the recombinant baculovirus constructed (AcNPV-ORF6) expressed 
pORF6. Mass spectrometry of the purified protein further confirmed the identity of the 
protein as pORF6, the ssDNA binding protein from KSHV.
To investigate the state of pORF6 in solution the protein was loaded onto a sizing 
column at a concentration of ~2mg/ml. However, running the sample through the 
column led to an inevitable dilution of the protein since the volume loaded onto the 
column was 200pi and pORF6 was eluted in 2mls of buffer it was diluted approximately
tenfold. It can therefore be concluded that pORF6 is monomeric up to 0.2mg/ml but may 
form higher order aggregates at higher concentrations.
As pORF6 had been purified and its state in solution had been investigated, it could now 
be used in experiments that characterise its binding to ssDNA. The following chapters 
describe such experiments.
Chapter 4 
EMSA analysis of pORF6 binding to
ssDNA
4.1 Introduction
Once the ORF6 protein had been successfully over-expressed and purified to 
homogeneity, it was necessary to ascertain whether the purified protein was functional. 
As other ssDNA binding proteins have been shown to bind to ssDNA in a cooperative 
manner, experiments were also carried out to characterise the binding of pORF6 to 
ssDNA. The experiments described in this chapter used an electrophoretic mobility shift 
assay (EMSA). The basis of the EMSA is that protein-DNA complexes remain intact 
when fractionated by gel electrophoresis and migrate as distinct bands, more slowly than 
the free DNA fragment.
This method was employed to investigate pORF6 binding to ssDNA since the binding of 
ICP8 (HSV-1) to ssDNA had been successfully studied using EMSA (Mapelli et a l , 
2000). An advantage of this method is that a qualitative result is gained by visual 
inspection with free and bound DNA being clearly distinguishable. For quantitative 
analysis, it is possible to determine the relative amount of radioactivity present in 
different DNA bands in the gel (volume analysis).
Volume analysis was carried out using the phosphorimager and associated software. 
Areas of the same size were highlighted around the DNA that needed to be determined 
and the amount of radioactivity within these selected areas quantified.
4.2 Purified pORF6 binds to ssDNA
To establish whether purified pORF6 could bind to ssDNA, an EMSA was employed 
using 32P labelled (dT)35 single-stranded oligonucleotides. After the pORF6 had been 
incubated with the labelled DNA the protein-DNA complexes were resolved on a gel, 
which was dried and exposed to a phosphorimage screen (figure 4.1a). Lane 1 has protein 
only loaded onto it, lane 2 contains the binding assay with both DNA and pORF6 and 
lane 3 the probe in absence of the protein.
In the absence of protein a fast migrating band corresponding to free DNA was seen 
(lane 3). Two additional slower migrating bands were observed when pORF6 was 
present (lane 2). These correspond to protein-DNA complexes and demonstrate that 
purified pORF6 can bind to ssDNA.
To gain further information on the process, the gel was stained with Coomassie blue 
(figure 4.1b). The lane with protein only (lane 1) shows most of the protein to be present 
as a slow migrating smear. There is also a band of protein that migrates more quickly, 
which may be a breakdown product. Incubation of pORF6 with the labelled probe (lane 
2) resulted in the appearance of two slower migrating bands (A and B), which correspond 
to the protein-DNA complex in figure 4.1. Bands A and B may represent two or one 
molecules, respectively, of pORF6 bound to the probe. Alternatively, they may represent 
binding of intact pORF6 and a smaller breakdown product.
The results in these figures show that the majority of the protein is capable of binding to 
DNA and that the preparation of protein is therefore highly active.
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Figure 4.1a pORF6 binds to ssDNA
pORF6 was incubated with 32P labelled ssDNA (dTbs for 30mins at 37°C. 60 pmole of 
labelled DNA was used in each reaction (30pl), except for lane 1 which was a control with 
pORF6 only (140 pmole) and no DNA. Lane 2 has DNA and pORF6 (140 pmole). Lane 3 
has DNA only. The DNA-protein complexes were resolved by EMSA. The gel was then 
stained with Coomassie blue, dried and exposed to a phophoimage screen. DNA bound by 
pORF6 and free DNA are labelled.
Figure 4.1b pORF6 binds to ss-DNA
Coomassie blue staining o f  the gel shown in figure 4. la
4.3 pORF6 requires between 14 and 20 nucleotides to bind to ssDNA
The estimated DNA binding site size for ICP8 (HSV-1 homologue of pORF6) is between 
12 and 40 nt, based on experiments investigating strand displacement and annealing 
activities (Boehmer and Lehman, 1993), nuclease protection (O’Donnell et al., 1987) and 
electron microscopy (Ruyechan and Weir, 1984). To investigate the length of DNA 
required for pORF6 to bind, an EMSA using 32P labelled DNA was again employed. 
Oligo-dT probes of 10, 12, 14, 20 and 28 nt (equimolar amounts) were incubated with 
pORF6 and the complexes were then resolved on a gel. Figure 4.2 shows the result of a 
representative experiment.
Binding of pORF6 to ssDNA occurred on lengths from 14 nt upwards. No binding was 
observed on oligonuceotide lengths shorter than this. Although binding to DNA 
occurred with the oligonucleotide length of 14 nt, the ability of the protein to bind to the 
DNA increased substantially when the DNA length was increased to 20 nt. As the length 
of DNA was further increased, binding of pORF6 to the DNA did not appear to increase, 
demonstrating that the 20 nt oligonucleotide was adequate for pORF6 to bind efficiently. 
Although the minimum number of nucleotides required for pORF6 to bind to ssDNA in 
this assay is fourteen, this clearly represents only a weak interaction with between 14 and 
20 nt being required for full activity.
4.4 The effect of NaCl on pORF6 binding to ssDNA
It is thought that protein-DNA interactions are particularly sensitive to changes in salt 
concentration due to the cations interacting with the nucleic acid. An investigation into 
the effect of the NaCl concentration on ICP8 binding to ssDNA revealed that optimal
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Figure 4.2 pORF6 requires greater than 12 nt to bind to ssDNA
pORF6 was incubated with '“P labelled ssDNA (poly dT) o f the indicated lengths 
(nucleotides) for 30mins at 37°C. Each 30pl reaction contained lOOpmole o f DNA and 
60pmole o f pORF6. The DNA-protein complexes were resolved by EMSA. The gel was 
then dried and exposed to a phophorimage screen, DNA bound by pORF6 and free DNA 
are labelled
binding occurred at 150mM NaCl with a sharp decrease in binding at 300mM (Lee and 
Knipe, 1985). Binding further decreased as the NaCl concentration was increased to 1M.
The effect of the NaCl concentration on the binding of pORF6 to ss-DNA was analysed 
by EMSA. A number of incubations were set up which were identical, except for the 
concentrations of NaCl which were 50mM, lOOmM, 150mM, 300mM, 500mM and 
lOOOmM. The complexes were resolved by EMSA. A representative example of this 
experiment is shown in figure 4.3a.
At high NaCl concentrations the mobility of the free DNA probe was affected. Binding 
of pORF6 to ssDNA was quantified by the amount of labelled DNA in the shifted band, 
which was determined by using the volume analysis program. Figure 4.3b shows a graph 
of these results. Maximal binding of pORF6 to ssDNA occurs at 150mM NaCl, the same 
as was observed for ICP8, by Lee and Knipe (1985), using a filter binding assay. 
However, the capacity of pORF6 to bind to ssDNA did not decrease as sharply at 
300mM NaCl as was found for ICP8. At this NaCl concentration the binding capacity of 
ICP8 had decreased by approximately two thirds. The concentration of NaCl required to 
elute pORF6 from a ssDNA column is 300mM, so it was expected that the amount of 
shifted complex would have been reduced dramatically. In addition, binding did not 
decrease as much as expected at the highest concentration of NaCl (1M).
These observations may be due to some dilution of the sample occurring when loading 
onto the gel, allowing increased binding of the protein to the DNA.
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Figure 4.3a Effect of NaCl on pORF6 binding to ssDNA
pORF6 was incubated with 2P labelled ssDNA (dT>2ofor 30mins at 37°C, in buffer 
containing the indicated final concentrations o f NaCl. The DNA-protein complexes were 
resolved by EMSA. The gel was then dried and exposed to a phophoimage screen. In each 
30pl reaction lOOpmole o f DNA and 60pmole o f pORF6 was used. DNA bound by pORF6 
and free DNA are labelled.
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Figure 4.3b Effect of NaCl on pORF6 binding to ssDNA
The amount o f DNA shifted in the EMSA in figure 4.3a was determined by volume 
analysis, as relative counts. This was plotted as a function o f NaCl concentration.
4.5 Titration of pORF6
Many ssDNA binding proteins have been found to bind to long ssDNA molecules 
cooperatively. This arises from direct protein-protein interactions between nearest 
neighbours (Alberts and Frey, 1970; Ruyechan, 1983).
The aim of the next experiment was to determine whether pORF6 binds to ssDNA in a 
cooperative manner. If pORF6 binds cooperatively to ssDNA it is expected that the 
relationship between the amount of DNA bound and the concentration of pORF6 would 
not be linear. Above a certain concentration of pORF6, the amount of DNA shifted 
would be more sensitive to an increase in concentration due to the second molecule of 
protein binding having a higher affinity for the DNA, if a cooperative binding model is 
occurring.
To investigate the binding of pORF6 to ssDNA a titration was carried out using fixed 
amounts of ssDNA ((dT)60) labelled with 32P and varying the concentration of pORF6. 
This length of DNA was used as it should accommodate more than one molecule of 
pORF6, since it was shown previously that pORF6 can bind to a minimum of 14nt in this 
type of assay. In each reaction there was 3 pmole of DNA. The pORF6 quantity ranged 
from 0 to 30 pmole. After incubation at 37°C, protein-DNA complexes were resolved by 
EMSA (figure 4.4a). Three shifted bands of DNA were observed, which probably 
represent three, two and one molecules of pORF6 binding to a molecule of ssDNA. This 
is indicated by a schematic diagram next to the figure.
The total amount of DNA shifted at the different concentrations of pORF6 used was 
calculated by densitometry and was plotted on a graph (figure 4.4b). The graph has a 
sigmoidal shape which is indicative of cooperative binding.
Inspection of the figure 4.4a also shows that the ssDNA probe used contains breakdown 
products. On comparing these breakdown products with a range of oligonucleotides that 
had been run on another gel under the same conditions, the smallest of these breakdown 
products was estimated to be approximatelyl5 nt in length. These shorter fragments will 
accommodate fewer ORF6 molecules than the 60-mer. With increasing pORF6 
concentration it can be seen that the longer DNA molecules are completely shifted into 
protein-DNA complexes before the smaller DNA molecules. This is again consistent 
with cooperative binding i.e. free pORF6 molecules bind with higher affinity to a 
protein-DNA complex (provided there is space) than to free DNA.
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Figure 4.4a Titration of pORF6 binding to ssDNA
Different amounts o f pORF6 were incubated with 3 pmole ,_P labelled ssDNA (dT)6o- 
The amount o f  protein in each reaction is shown underneath in pmol. The DNA- 
protein complexes were resolved by EMSA. The gel was then dried and exposed to a 
phosphorimage screen. The breakdown products o f the DNA probe are indicated with 
the approximate size o f the smallest breakdown product shown. A schematic is 
shown o f the number o f  molecules o f pORF6 possibly binding to the ssDNA in the 
shifted complexes.
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Figure 4.4b Titration of pORF6 binding to ssDNA
The amount o f DNA shifted in figure 4.4a was determined by volume analysis, as 
relative counts. This was plotted as a function o f amount o f protein. Amounts o f 
pORF6 > 15 pmole are not shown.
4.6 Discussion
The work described in this chapter produced results that gave both qualitative and 
quantitative information on the binding of pORF6 to ssDNA. Firstly it demonstrated that 
the pORF6 that had been over expressed and purified could bind to ssDNA and that the 
majority of molecules could participate in the formation of a protein-DNA complex and 
was therefore functional (figure 4.1).
The DNA molecules used in these experiments were dT homopolymers. These were 
used to ensure that there would be no secondary structure formed in the DNA, which 
may have interfered with binding. Future experiments could use heteropolymers to 
investigate whether this makes a difference to pORF6 binding to ssDNA, since this is 
what pORF6 would bind to in vivo. Another difference that could be made when 
conducting future experiments would be to use ficoll in the binding buffer instead of 
glycerol. Both of these agents are used in protein buffers to stabilise the protein. 
However, the use of ficoll apparently reduces the smearing of the edges of the DNA 
bands that have been bound by the protein (Gamer and Revzin 1991). This would make 
quantification of the phosphorimage easier and more accurate.
One of the quantitative results for the binding of pORF6 to ssDNA was the observation 
of the minimum number of nucleotides required for pORF6 to bind to ssDNA being 
between 14 and 20 nt. As mentioned previously, the number of nt required for ICP8 to 
bind to ssDNA varied depending on the type of assay used, being between 12 and 40 nt.
It would be interesting to carry out these assays using pORF6 to see if the same 
variations occurred.
NaCl concentration has an effect on the binding of SSBs to DNA. Two binding modes 
have been identified in the E.coli SSB when bound to ss-DNA, that are dependent on 
NaCl concentration (Lohman and Overman, 1985). As NaCl concentration increases the 
DNA binding site size also increases from 33nt to 65nt. Cooperativity of binding to ss­
DNA of the E.coli SSB also changes with NaCl concentration, with the level of 
cooperative binding decreasing as NaCl is increased (Lohman et al., 1986). At the lower 
NaCl concentrations (below lOmM) unlimited cooperative binding is observed with long 
chains of protein binding to the ss-DNA. At the higher NaCl concentration (above 
200mM) limited cooperative binding is observed with the protein binding to the DNA as 
dimers. These observations suggest that increasing NaCl concentration may affect the 
protein-protein as well as DNA-protein interactions. Kowalczykowski et al. (1981) 
demonstrated that the binding constant of gp32 (T4 bacteriophage) to polynucleotides 
decreased as the NaCl concentration was raised above 200mM. The cooperativity 
parameter however did not change. A similar phenomenon was also shown for DBP 
from the adenovirus (Kuil et al., 1989).
A change in NaCl also had an effect on the binding of pORF6 to ssDNA (figure 4.3). 
Although binding was observed at low NaCl, 150mM NaCl was required for maximal 
binding. As the concentration of NaCl was increased above 150mM the ability to bind to 
DNA decreased. Since figure 4.3 was performed using (dT)2o it is not possible to 
determine whether NaCl concentration affected cooperativity. It would be interesting to 
repeat this experiment with the (dT)6o probe used in figure 4.4 and to quantify the total 
amount of shifted DNA and whether NaCl affects the relative binding to the shorter 
breakdown products in the same way as to the (dT)6o-
ssDNA binding proteins characteristically bind to ssDNA in a cooperative manner. It is 
thought to aid their role in recombination, repair and replication. During initiation of 
replication, as an area of DNA becomes unwound to reveal ssDNA the SSB begins to 
bind to the area. Additional molecules then bind with greater affinity, keeping the DNA 
strands apart. As the replication fork advances, cooperative binding of the protein to the 
DNA results in a protein chain being formed along the lagging DNA strand. (Ruyechan, 
1983; Alberts and Frey, 1970; Kuil et a l , 1989; Boehmer and Nimonkar, 2003). This 
holds the DNA in an extended conformation, which facilitates the polymerase activity 
and also protects the ssDNA from nuclease digestion.
The titration of pORF6 with ssDNA revealed that pORF6 may bind to ssDNA in a 
cooperative manner, consistent with its proposed role during DNA replication. This 
experiment needs to repeated to confirm that pORF6 binds cooperatively. If this is 
confirmed, future work could also employ deletion and point mutations within the 
protein to identify the residues involved in cooperative binding.
A deletion mutant of ICP8 was constructed that had the 60 C-terminal amino acids 
deleted and also had two internal cysteine residues changed to serines. The ability of the 
protein to bind to oligo- dT probes of 14, 20, 28 and 35 was investigated by EMSA 
(Mapelli et al., 2000). The analysis indicated that neither removal of the 60 C-terminal 
amino acids or the two internal mutations affected the intrinsic ability of ICP8 to bind to 
ssDNA. However, the C-terminal deletion mutants exhibited a loss of cooperativity on 
the longer DNA molecules (20-35 nt). A similar phenomenon was observed in a deletion 
mutant of the human mitochondrial SSB that had the 60 C-terminal amino acids removed 
(Curth et al. 1994). Again the implication is that the C terminus is involved in the 
molecular mechanism of cooperativity. Hooking of the 17 residue C-terminal region of
the adenovirus DBP to the nearest neighbour on the protein bound to ssDNA has been 
observed by crystallography and is presumed to be the mechanism by which the protein 
binds cooperatively (Tucker et al., 1994).
After confirmation that pORF6 binds to ssDNA cooperatively, it would be interesting to 
make a similar deletion to pORF6 and to investigate its effect on it binding to ssDNA to 
see if the C-terminus of this protein, like some of its homologues is involved in co­
operative binding. If deleting the 60 C-terminal had the same effect as it had on ICP8, 
additional deletion mutants could be made to further locate the region critical for co­
operative binding e.g. 50, 40, 30 etc amino acids deleted.
Chapter 5
BIAcore analysis of pORF6 binding to
ssDNA
5.1 Introduction
This chapter describes work that was carried out using a BIAcore 2000, which utilizes 
surface plasmon resonance (SPR) and continuous flow technology to monitor molecular 
interactions in real time. This is an advantage over other methods that investigate 
binding, which only give a ‘snap shot’ of the events occurring during association, 
equilibrium and dissociation. Using the BIAcore, the entire events of association, 
equilibrium and dissociation can be monitored, although it should be noted that the 
equilibrium stage seen is not a true equilibrium but is actually a steady state, as it is an 
open system that is being continually supplied with ligand dissolved in buffer. This 
approach was used to investigate further the interaction of pORF6 binding with ssDNA.
Surface plasmon resonance is a phenomenon that occurs when light is reflected off thin 
metal films. A fraction of the light energy incident at a sharply defined angle can interact 
with the delocalised electrons in the metal film (plasmon) thus reducing the reflected 
light intensity. The precise angle of incidence at which this occurs is determined by a 
number of factors, but in the BIAcore the principal determinant is the refractive index 
close to the backside of the metal film. Target molecules are immobilised on this surface 
(ligand) and bound by molecules in a mobile phase (analyte) running along a flow cell. If 
binding occurs to the immobilised target, the local refractive index changes, leading to a 
change in SPR angle, which can be monitored in real-time by detecting changes in the 
intensity of the reflected light. The change in SPR angle can be related to a resonance 
signal indicative of the mass bound to the chip and plotted over time to produce a 
sensorgram.
The essential components of the BIAcore system are the sensor chip where the 
interaction takes place, the optical system responsible for the generation and the 
detection of the SPR signal and the liquid handling system for the transport of samples to 
the sensor surface (sensor chip).
As mentioned above, one of the molecules of interest is immobilized to the surface of the 
chip. The other molecule is free in solution, which flows over the chip surface. As 
molecules from the solution bind to the immobilized ligand, the resonance angle changes 
and a response is registered. Figure 5.1 shows a diagram outlining the events.
The raw data are presented as a real-time graph of response units (RU) against time and 
is referred to as a sensorgram. During injection of analyte, changes in signal result from 
two processes: association to and dissociation from the surface. At the end of injection, 
running buffer continues to flow over the chip; at this stage the change in signal results 
from dissociation only. Figure 5.2 depicts the details of a sensorgram.
The experiments detailed in this chapter were carried out by immobilizing ssDNA to the 
chip and injecting a solution containing pORF6 over it. The chips used were coated with 
streptavidin. The ssDNA was adhered to the chips by using ssDNA with a 5’biotin end 
label and taking advantage of the strong interaction between streptavidin and biotin (K d 
= 10'14 M). It is important to ensure that the chip is regenerated properly between each 
injection of analyte and that the baseline returns to its initial level. This was achieved by 
injecting a 0.5M NaCl solution over the chip, which eluted any protein remaining on the 
chip. For all experiments the BIAcore was set to 37°C.
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Figure 5.1 Surface plasmon resonance on the BIAcore
A diagram showing the details o f events on the BIAcore. The analyte is flowed over the 
cell in which the ligand has been adhered. Binding o f the analyte to the ligand causes a 
change in the angle o f reflection o f the polarised light beam that is applied to the gold film 
on the sensor chip. This is converted into a resonance signal. Adapted from 
www.biacore.com
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Figure 5.2 Details of a curve produced using the BIAcore
Shown is a schematic o f  a curve created using the BIAcore with the different areas labelled 
Adapted from www.biacore.com.
As a control, one of the flow cells on the chip was not reacted with the DNA ligand. The 
same dilutions of pORF6 were also applied to this flow cell and the signal generated was 
subtracted from the flow cell containing DNA.
The majority of work was carried out on the BIAcore 2000. One of the advantages this 
has over the BIAcore 1000 is that the same injection of protein is flowed over both the 
cell with DNA attached, and the control cell, and the signal generated by the control cell 
is automatically subtracted from the cell with DNA bound. It is important that this is 
done as the buffer by itself produces a signal. Figure 5.3 shows an example with the 
signal from both the experimental and control cell and the automatic subtraction to give 
the signal representing specific binding.
5.2 pORF6 binding to ssDNA
It was firstly determined whether binding of pORF6 to ssDNA could be detected by 
surface plasmon resonance using the BIAcore. An oligonucleotide of 32nt that was 5’ 
biotin labelled, was attached to one of the flow cells on a streptavidin chip. This was 
carried out by injecting a DNA solution in running buffer over the chip until 
approximately 100 response units of DNA had been attached. Free biotin was then 
flowed across the cell to block any free streptavidin sites, which may have produced 
background binding. The following concentrations of pORF6 were flowed across the 
DNA-containing and control flow cells: 160nM, 80nM, 40nM, 20nM, lOnM and 5nM. 
The serial dilutions of pORF6 were made using the running buffer, which was a hepes 
buffer. A regeneration injection of 0.5M NaCl was flowed across between each protein 
application. The curves from the sensorgram were aligned using the BIAevaluation 
software.
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Preliminary experiments used an association time of 120 seconds and did not reach 
steady state (Figure 5.4). However, the data demonstrated that pORF6 does bind to 
ssDNA in this assay and that the initial rate of binding increases as concentration of 
pORF6 increases. Label A indicates when the ligand was applied (association and 
dissociation occurring) and label B shows where only buffer is applied (dissociation is 
occurring).
The experiment with the ssDNA was repeated with an association time of 180 seconds, 
which allowed a steady state to be reached. The dissociation time during which running 
buffer minus analyte was applied was also 180 seconds. Figure 5.5a presents the raw 
data from the experiment as a sensorgram showing several sequential applications. The 
points at which the chip was regenerated with NaCl are indicated on the figure. Figure 
5.5b shows the transformed data for this experiment.
This figure again demonstrates that the initial rate of binding increases as the 
concentration of pORF6 is increased. It also shows that the steady state level increases 
with increasing pORF6 indicating that more pORF6 is bound as its concentration 
increases.
To investigate the relationship between the concentration of pORF6 and the amount of 
pORF6 bound to ssDNA at equilibrium (steady state), a graph was plotted of the two 
variables (figure 5.6). The data used for this graph was derived from the curves shown in 
figure 5.5b.
The shape of the curve appears sigmoidal suggesting that pORF6 may be binding to 
ssDNA in a cooperative manner in this assay. This is reminiscent of the data obtained in
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mobility shift assays shown in figure 4.4b, which also demonstrated a sigmoidal response 
between the amounts of pORF6 binding to ssDNA at equilibrium, and the pORF6 
concentration. Again further experiments would need to be done to strengthen the 
conclusion that pORF6 binds cooperatively. It should be noted that binding had not 
reached saturation by 80 mM pORF6 and further experiments using higher 
concentrations of pORF6 would be required to determine whether the signal observed 
with 160 nM corresponds to saturation. It would also be informative to include 
concentrations in between the points already used.
5.3 A comparison of pORF6 binding to oligonucleotides of 15 and 32 nt in length
As two molecules of pORF6 can bind to a ssDNA probe of 32 nt, it was decided to 
investigate binding of pORF6 to a DNA length that would accommodate only one 
molecule of pORF6. A 5’ biotin end labelled oligonucleotide of 15 nt was attached to a 
chip to approximately 100 response units and pORF6 was flowed across it. The raw data 
from the binding of pORF6 to the 15 nt DNA strand was aligned and compared with raw 
data from pORF6 binding to the 32 nt DNA strand. The curves were aligned using the 
BIAevaluation software. Figure 5.7 shows the curves generated with 80nM pORF6 
applied to the flow cells with both the 32 nt and the 15 nt DNA strands attached.
The initial rate of association of pORF6 with the ssDNA is greater for the 32 nt DNA 
strand that for the 15 nt strand. Inspection of the dissociation phase shows the slope for 
the 15 nt DNA to be much steeper than for the 32nt DNA. The majority of pORF6 
appears to dissociate rapidly from the 15 nt DNA whereas it dissociates at a much slower 
rate from the 32 nt DNA.
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pORF6 therefore has a greater affinity for the 32 nt DNA strand than for the 15 nt strand 
DNA. This is probably because two molecules are binding to the 32mer and binding of 
the second molecule occurs cooperatively whereas only one binds to the 15mer. 
However, the mobility shift assay in figure 4.2 demonstrated that although pORF6 binds 
to ssDNA of 14 nt, it binds with a greater capacity to ssDNA of 20 nt. Thus a ssDNA of 
15 nt may not be sufficiently long to enable optimum binding of a single pORF6 
molecule. In addition, because the ssDNA is linked to the chip surface its full length 
may not be available for unhindered binding of pORF6.
5.4 A comparison of ICP8 and pORF6 binding to ssDNA
It was next decided to compare ICP8 and pORF6 binding to ssDNA. As ICP8 is the SSB 
from HSV-1 it was expected that its binding to ssDNA would be similar. ICP8 was 
purified using the same methods as were used for purifying pORF6 (section 3.8).
Binding was investigated using the 32nt ssDNA probe. A series of dilutions of ICP8 
were made and these were individually applied to the flow cell. Curves generated using 
the same concentration of each protein (pORF6 and ICP8) were aligned and compared 
with each other. Figures 5.8a and 5.8b show the aligned curves for 40 nM and 80 nM 
applied protein, respectively.
The initial association rates for both proteins were similar, but ICP8 did not reach 
equilibrium in this time period, suggesting that the association rate for pORF6 may be 
greater. However, the dissociation rate of pORF6 from ssDNA in both cases appeared to 
be greater than for ICP8. The overall affinity of each protein for ssDNA is therefore 
likely to be similar. To establish this, the affinity constant would need to be calculated. 
For simple bimolecular interactions the affinity constant Kd = kd/ka. However, the
interactions of ICP8 and pORF6 with a 32 nt ssDNA strand are more complex since 
more than one molecule can interact with DNA and binding is cooperative, and Kd 
values calculated by the above formula are not meaningful. However, consistent with the 
two proteins exhibiting similar overall affinities it can be seen that the steady state 
binding levels were probably also very similar, although ICP8 had not quite reached 
equilibrium.
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5.5 Discussion
This section of work further investigated pORF6 binding to ssDNA and it provided 
additional evidence that the protein may bind to ssDNA in a cooperative manner, 
although this work needs repeating and extending to corroborate this. A comparison of 
pORF6 binding to ssDNA strands of 32 and 15 nt demonstrated a higher affinity for the 
32nt strand. However, unlike the 15 nt strand the 32 nt DNA strand used was not a 
homopolymer. This work needs be repeated with a 32 nt poly dT strand to confirm that 
the difference is due solely to the length of the ssDNA strand rather than its composition 
or sequence.
In the experiment comparing the binding of pORF6 and ICP8 to ssDNA (figure 5.8), 
good data was not achieved at all of the concentrations of ICP8 used. This work could be 
repeated and extended to different lengths of ssDNA strands, and the relationship of 
steady-state binding levels to ICP8 protein concentration investigated as in figures 5.6 
and 5.7 to gain a more complete comparison of the two proteins. Nethertheless the data 
presented in figure 5.8 suggests that there are differences between the kinetics of 
interaction of the two proteins with ssDNA. Even though their overall affinities for 
ssDNA appear similar it is not clear whether the differences reflect between the protein- 
DNA or protein-protein interactions or both.
Initially pORF6 binding to dsDNA was also investigated. On repeating this experiment 
to achieve equilibrium pORF6 did not bind to the dsDNA. This may be due to the DNA 
having been degraded on storage. Future work would investigate the binding of pORF6 
to dsDNA using the BIAcore and comparing it to ssDNA.
One of the advantages of using the BIAcore system to study binding rates is that the 
whole event of association, equilibrium and dissociation is monitored. Using the BIA 
core to investigate DNA-protein interactions does not impose structural constraints on 
either of the molecules being investigated if the DNA is bound to the chip. Binding the 
DNA to the chip via a 5’biotin label should not alter the structure of the DNA or inhibit 
its dynamic movement. This contrasts with the situation when the BIAcore is used to 
characterise protein-protein interactions during which one of the proteins is attached to 
the chip. This is usually achieved by binding free amine groups on the protein to a 
carboxymethylated dextran chip. A disadvantage of this is that the protein is no longer 
dynamic which may inhibit conformation changes associated with binding to another 
molecule. The orientation in which the protein is fixed to the chip may also be 
inappropriate, resulting in the masking of a binding site.
Chapter 6
Generation and charaterisation of pORF6
specific MAbs
6.1 Introduction
The purification of native pORF6 was described in chapter 3. This chapter describes the 
use of that protein to generate a panel of monoclonal antibodies and their preliminary 
charaterisation.
Antibodies are an important tool in the study of proteins and their function. Mono­
clonal antibodies (MAbs) are especially useful as their highly specific and unique 
binding properties can be exploited for many purposes. A further advantage is that they 
can be produced repeatedly and in limitless quantities. Producing MAbs would be 
expected to give rise to a range of antibodies, each with unique individual specificities, 
but collectively, with reactivity to a variety of epitopes on the ORF6 protein. The 
production of a panel of MAbs is also more likely to result in a selection of antibodies, 
which are suitable for a wider range of applications. This is an important consideration, 
as polyclonal antiserum does not always suit every application. Also, once epitope- 
mapping of a monoclonal antibody has been carried out, its unique specificity to a 
defined region can often be employed in relating protein structure to function.
Having isolated MAbs, it is necessary to characterise their properties to determine their 
affinities and the applications in which they may be useful. This is an important 
objective as the hybridoma cell lines used in this study were selected and isolated on the 
basis of screening against pORF6 in ELISA only. Immunochemical techniques used to 
test the reactivities to pORF6 of each monoclonal were western blotting, immune 
precipitation and immunofluorescence.
Principles of monoclonal antibody production
MAbs are secreted from single clones of hybridoma cells. These cells are created 
following the fusion of mutant myeloma cells that have lost the ability to produce 
hypoxanthine phosphoribosyltransferase (HPRT) and therefore cannot synthesise purines 
via the salvage pathway, and antibody-producing immune lymphocytes. Polyethylene 
glycol (PEG) is the agent used to promote membrane fusion between the cells in a 
process first described by Kohler & Milstein (1975). Hybridoma cells inherit both 
immortality from the myeloma cells and antibody-producing capability from the B 
lymphocytes. Following fusion, the hybrid cells are selected from the mixture of spleen 
cells, myeloma cells and hybrids by the addition of HAT (hypoxanthine, aminopterin, 
thymidine) to the culture medium. Aminopterin is an antibiotic that inhibits de novo 
nucleic acid synthesis by blocking purine and pyrimidine synthesis. However in normal 
cells, this pathway can be bypassed by using the salvage pathway, which requires the 
substrates hypoxanthine and thymidine for purine and pyrimidine synthesis, respectively. 
As the mutant myeloma cells are deficient in the salvage pathway, they do not survive. 
Neither do the unfused spleen cells due to their limited life span in culture. Hence the 
only cells that survive are hybrid cells that have inherited the ability to utilise the salvage 
pathway from the spleen cells and long-term viability from the myeloma cells. Some of 
these hybrid cells will also have antibody producing capacity of the splenic lymphocytes. 
The culture supernatant from single colonies of the hybridoma cells is then tested for the 
presence of the antibodies of the desired reactivity. Cell lines positive for the secretion 
of antibody are propagated and frozen down at -140°C for long-term storage.
6.2 Generation of pORF6 MAbs
pORF6 was purified as described in Materials and Methods and mice were immunised as 
described in methods. 33 hybridoma cell lines secreting pORF6-specific antibodies were 
isolated following the fusion of Sp2/0-Agl4 myeloma cells and spleen cells from the 
immunised mice. Positive cell lines were identified by using the hybridoma supernatant 
in an ELISA. An OD reading was taken and the supernatant was deemed positive if  it 
produced a reading more than twice than that produced by control supernatant from Sp-2 
cells.
6.3 Reactivity of pORF6-specific MAbs to pORF6 over-expressed in S f  cells in 
western blotting assays
For western blot analysis of the MAbs that had been raised against pORF6, cell extract 
was made from S f  cells that had been infected with a baculo virus (AcNPV-ORF6), 
expressing pORF6. As a positive control, polyclonal antibody 726 (anti-peptide antibody 
raised against the C -terminus of pORF6) was used. Negative controls were western 
blots using cells infected with the parental baculovirus (PAK6) and a control MAb 
against a different protein, UL8 (HSV-1).
The thirty-three MAbs that had been positive in an ELISA were tested and twenty-two of 
these reacted positively in a western blot. As some breakdown of the ORF6 protein used 
on the blot had occurred, different patterns of reactivity were observed with the MAbs 
suggesting reaction with different regions of the protein. Representative reactions are 
shown in figure 6.1. By comparing the pattern of the western blots with that of a western 
blot using Ab726 (figure 6.1a), which reacts against the very C-terminus of pORF6, three 
patterns of reactivity could
Breakdown 
Product X 
(~30kDa)
 ► ^am
Full length pORF6
a b c d
(Ab726) (52) (141) (160)
J
Figure 6.1 Reactivity of pORF6-specific MAbs to pORF6 over-expressed in S f  cells in 
western blotting
Cell extract from S /cells that had been infected with AcORF6 was resolved by SDS-PAGE 
and blotted nitrocellulose which was then cut into strips. The strips were incubated in 1ml 
o f MAbs (undiluted supernatant from individual hybridoma cell lines), Ab726 or control 
hybridoma cell supernatant. Strips were then washed and incubated with either anti-mouse 
HRP-conjugated antibody or anti-rabbit HRP-conjugated antibody, as appropriate. After 
further washing, strips were treated with ECL reagents and exposed to photographic film.
NCleavage point
T
t
Twelve o f  the MAbs 
reacted against this 
region o f the protein
t
Ten o f the MAbs 
reacted against the C- 
terminal region o f the 
protein (~ 30 kDa)
Eleven o f the MAbs did not react 
towards pORF6 in a western blot
Figure 6.2 Regions of pORF6 that the MAbs react towards in a western blot
A schematic diagram o f the pORF6 protein showing the putative regions with which the 
MAbs react.
be deduced. One group of the MAbs, exemplified by MAb 52, gave a similar reaction 
pattern to that of Ab726, as a strong reaction to the full length protein and a strong 
reaction to a breakdown product (x ~ 30kD) towards the bottom of the blot, was observed 
(figure 6.1-b). This leads to the suggestion that these MAbs are reacting to an epitope 
near the C-terminus of pORF6.
Another set of the MAbs (exemplified by MAb 141) reacted to the whole protein and 
also to breakdown products not much smaller than pORF6, while other MAbs 
(exemplified by Mab 160) reacted to both these and intermediate size fragments (figure 
6.1- c&d). It can be deduced that both these sets of MAbs interact with epitopes that lie 
outside the C-terminal ~ 30 kDa. Figure 6.2 summarises the reactivity of the MAbs 
towards pORF6 in a western blot.
6.4 Reactivity of pORF6-specific MAb 15 to pORF6 in HHV8 infected B-cells in 
western blotting assays
As many of the MAbs could react with pORF6 that had been over-expressed in S f  cells, a 
western blot assay was carried out using cells that were infected with KSHV to ascertain 
whether levels of pORF6 in a natural infection were sufficient to be detected. A B-cell 
line (BCBL1) latently infected with KSHV, which had been established from a primary 
effusion lymphoma, was used. To induce the virus into lytic infection, sodium butyrate 
was added. At 24, 48 and 72 hours post induction cell extracts were made and analysed 
in a western blot (figure 6.3). As controls, cell extracts of uninduced cells were also made 
at these times and a B-cell line not infected with KSHV (BJAB) was also used.
24(1) 24 48(1) 48 72(1) 72 BJAB
Figure 6.3 Reactivity of pORF6-specific MAb with pORF6 in HHV8 infected B-cells.
B cells that were latently infected with HHV8 were induced with sodium butyrate. At the 
indicated times (h) post induction cell extracts were made. The proteins were resolved by 
SDS-PAGE and blotted onto nitrocellulose. The nitrocellulose was incubated in 1ml o f 
MAb (undiluted supernatant from individual hybridoma cell lines). The membrane was 
then washed and incubated with anti-mouse HRP-conjugated antibody. After further 
washing, the blot was treated with ECL reagents and exposed to photographic film. As 
controls, uninduced cells and also a B-cell line uninfected with HHV8 were used (BJAB). 
The numbers indicate hours after induction the cell extracts were made. Cells that were 
induced are represented with (I) after the number. An anti- ft-actin MAb was also used to 
confirm that a similar amount o f  cells had been used in each lane.
A western blot of these samples was reacted with MAb 15 (figure 6.3). pORF6 was 
detected at 48h and 72h in the induced samples but not at any time in the uninduced or 
BJAB controls. To confirm the same amount of cells had been loaded onto the wells an 
antibody against P-actin was also used. After chemical induction, KSHV early genes can 
be detected at about 13 hours (Sun et a l , 1999) and so pORF6 had probably not 
accumulated to a high enough level for the Mab to detect by 24h. The decrease of 
pORF6 at 72 hours is probably due to cell viability decreasing as sodium butyrate is toxic 
to the cells, and an associated breakdown of pORF6.
6.5 Reactivity of pORF6-specific MAbs to pORF6 over-expressed in S f  cells in 
immune-fluorescence assays
The MAbs were also tested to see if they could react to pORF6 over-expressed in S f  
cells, in an immune-fluorescence assay. The cells, which had been infected with 
AcNPV-ORF6 for 48hrs were mounted onto slides using a cytospin. The cells were then 
fixed, permeabilised and incubated with the MAbs and subsequently an anti-mouse-FITC 
conjugated antibody. Controls used were S f  cells infected with the parental baculo virus 
(PAK6) and a control Mab was also used (anti-HSV-1 UL8). The stained cells were 
visualised using the LSM 510 (Zeiss) confocal microscope. Figure 6.4 shows the pattern 
obtained with one of the positive MAbs, MAb 199. In total eighteen out of the thirty- 
three antibodies gave a positive result. The pORF6 was located in the nuclei of infected 
S f  cells in agreement with its previously demonstrated intrinsically nuclear location in 
Vero cells (Wu et a l, 2001).
AcNPV-ORF6 PAK6
AcNPV-ORF6
■
 Control 
UL8 MAb
Figure 6.4 Reactivity of pORF6-specific Mabs with pORF6 over-expressed in S f  cells 
in immune-fluoresence
5/^cells were infected with a recombinant baculovirus expressing pORF6 or the parental 
baculovirus (control). After 48hrs infection they were mounted onto slides using a cytospin, 
fixed and permeabilised and incubated with MAbs. After washing the cells were incubated 
with an anti-mouse-FITC conjugated antibody and visualised using a confocal microscope 
(LSM 510, Zeiss). AcNPV-ORF6 infected cells were also reacted with a control MAb 
against the HSV-1 UL8.
6.6 Reactivity of pORF6-specific MAbs with pORF6 in HHV8 infected B-cells in 
immune-fluoresence assays
As some of the MAbs were positive by immune-fluorescence for interaction with pORF6 
over-expressed in S f  cells, it was next determined if similar reactivity could be observed 
in cells infected with KSHV. Again B-cells latently infected with KSHV were used. 
Cells were induced using sodium butyrate (20-40% are usually induced) and after 48 
hours they were mounted onto a slide, fixed with acetone/methanol and then incubated 
with MAbs 15 and 199. They were then incubated with anti-mouse-Cy5 conjugated 
antibody. A Cy5 conjugated antibody was used in this experiment as the virus expresses 
GFP, which fluoresces at the same wavelength as FITC. MAbs 15 and 199 reacted with 
pORF6 in this assay (figures 6.5 a and 6.5b) and nuclear staining was again observed 
(panels B and D, figure 6.5a; panel B figure 6.5b).
To visualise the nucleus more clearly, the cells were also stained with DAPI, which binds 
to DNA. pORF6 was found in globular areas, typical of herpesvirus replication 
compartments in agreement with previous data demonstrating that KSHV replicates in 
such structures (Wu et a l, 2001). The DAPI staining seemed to be confined largely to 
regions outside those containing pORF6 (figure 6.5a, A-C and figure 6.5b, A-C). In the 
case of HSV-1, cellular chromatin is pushed aside and becomes condensed as the viral 
replication compartments expand (Monier et a l , 2000). This may also be occurring here 
and could account for the appearance of the cellular DNA. Presumably there will be 
viral DNA within the replication compartments, but this may not be visibly stained by 
the DAPI because there is a large excess of stained cellular DNA.
Figure 6.5a Reactivity of pORF6-specific MAbs to pORF6 in KSHV infected B- 
cells in immune-fluoresence assays
B-cells that were latently infected with KSHV were induced into lytic infection by 
adding sodium butyrate. At 48hrs they were mounted onto slides, fixed with 
methanol/acetone and then incubated with pORF6- MAbl5. After washing they were 
incubated with anti-mouse-Cy5 conjugated antibody. Following further washing they 
were stained with DAPI. As a control cells that were uninduced were used. A 
control MAb (against HSV-1 UL8) was also used on induced cells. A-C induced cells 
incubated with MAbl5 (A,merged image; B, Cy5; C, DAPI); D, induced cells 
incubated with MAbl5, showing Cy5 staining; E, uninduced cells incubated with 
MAb 15 showing Cy5 staining; F, induced cells incubated with control antibody 
(UL8).

Figure 6.5b Reactivity of pORF6-specific MAbs to pORF6 in KSFIV infected B- 
cells in immune-fluoresence assays
B-cells that were latently infected with KSHV were induced into lytic infection by 
adding sodium butyrate. At 48hrs they were mounted onto slides, fixed with 
methanol/acetone and then incubated with pORF6- M Abl99. After washing they 
were incubated with anti-mouse-Cy5 conjugated antibody. Following further 
washing they were stained with DAPI. As a control, cells that were uninduced were 
used. A-C induced cells incubated with M Abl99 (A, merged image; B, Cy5; C, 
DAPI staining); D- uninduced cells incubated with MAb 15 showing Cy5 staining
6.7 Reactivity of pORF6-specif!c MAbs with pORF6 over-expressed in S f  cells in 
immune-precipitation assays
S/cells were infected with recombinant baculovirus AcNPV-ORF6. After 24 hours the 
medium was replaced with methionine-free medium containing S-methionine and 
incubated for a further 24 hours. Cells were harvested and washed in TBS, then proteins 
were extracted in cold AE buffer and incubated with MAbs at 4°C. A suspension of 
protein A sepharose beads was added. After mixing for 1 hour the beads were pelleted 
by centrifugation, washed in AE buffer boiled in SDS-PAGE buffer. The beads were 
pelleted by centrifugation and the supernatant was analysed by SDS-PAGE. The gels 
were dried and then exposed to a phosphorimage screen. A representative experiment 
using some of the MAbs is shown in figure 6.6. As a control S f  cells infected with the 
parental baculovirus (PAK6) were also used. Some of the Mabs reacted strongly e.g. 199 
while others reacted weakly e.g. 1 and 15 or not at all e.g. 120. In total, ten of the Mabs 
were able to immune-precipitate pORF6.
6.8 A protein in the hybridoma supernatant binds to ssDNA
To give more information on the binding of pORF6 to ssDNA, it was decided to test the 
effect of the MAbs in an EMSA with pORF6 and ssDNA. This would be expected to 
result in a supershift of the DNA-pORF6 complex, or, depending on which part of the 
protein the antibody bound, to, might result in pORF6 no longer being able to interact 
with ssDNA. Such an approach would help to elucidate the region of pORF6 involved in 
ssDNA binding. MAb52 was chosen for an initial experiment as it had reacted well in 
the immune assays. Binding assays were set up with MAb, pORF6 and P-labelled poly 
(dT)35. After incubation complexes were resolved by on an acrylamide gel, which was 
dried and exposed to a phosphorimage screen (figure 6.7).
apORF6
MI CE 1 15 199 120
Figure 6.6 Reactivity of pORF6-speciFic MAbs in immune-precipitation assays
S f  cells were infected with recombinant baculovirus AcNPV-ORF6. After 24 hours the 
medium was replaced with methionine-free medium containing S-methiomne and 
incubated for a further 24 hours. Extracts were prepared and immune-precipitated with the 
MAbs. Samples o f extract from mock-infected (MI) and infected (CE) cells were analysed 
alongside the immunoprecipitates by SDS-PAGE. A phosphorimage o f  the dried gel is 
shown. The numbers correlate to the Mab used.
Unknown protein- 
ssDNA complex
pORF6-ssDNA
complex
1 2 3
Figure 6.7 A protein in the hybridoma supernatant binds to ssDNA
Binding assays were carried out containing 1- MAb52 and (dT )35 2-MAb52, pORF6 and (dT)35 
3- (dT )35 for 30 mins at 37°C. Prior to addition o f DNA the MAb and pORF6 were incubated 
for 1 hour at 37°C. The DNA-protein complexes were resolved by EMSA and the gel was then 
dried and exposed to a phophorimage screen.
On inspecting the lane 2, which contained all the components, a novel additional band 
migrating more slowly than the pORF6 complex was apparent suggesting that the 
antibody might be binding to, and further reducing the mobility of the complex.
However, the control with MAb and ssDNA only, revealed that the slower migrating 
band represented a protein from the hybridoma supernatant (probably from the foetal calf 
serum) binding to the DNA. The MAb was therefore purified from the supernatant 
medium in an attempt to remove this binding activity.
6.9 Purification of MAb 52 raised against pORF6
MAb 52 was purified using a protein G column. Thirty mis of the hybridoma 
supernatant was dialysed overnight in the protein G column running buffer and applied to 
the column. The MAb was eluted using a glycine buffer (pH 2.7) into tubes containing 
1M TRIS-HC1 (pH 9) to neutralise the eluant. Figure 6.8 shows a chromatogram of the 
purification. The antibody was eluted in three 0.5ml fractions. To verify the purity of 
the antibody, samples were resolved by SDS-PAGE and the gel was then stained with 
Coomassie blue (figure 6.9). The presence of heavy and light chains of the antibody 
confirmed that the antibody had been purified to near homogeneity.
Unfortunately due to time constraints the EMSA experiments with the purified MAb 
were not completed. This is work that could be done in the future.
Glycine buffer (pH 2.7) 
Applied here
Mab52
io"o 40.0
Figure 6.8 Purification of MAb52 raised against pORF6
Thirty mis o f dialysed hybridoma supernatant was loaded onto the protein G column using 
a sodium phosphate buffer. MAb 52 was eluted from the column using a glycine buffer 
(pH 2.7). The antibody was eluted in three 0.5 ml fractions. The trace shows the UV 
absorbance o f fractions and the position o f the peak o f eluted antibody.
Heavy chain
Light chain
Figure 6.9 Purification of iVIab raised against pORF6
The peak fractions from the purification (figure 6.8) were resolved by SDS-PAGE. The 
gel was then stained with Coomassie blue. As it is a denaturing and reducing gel the heavy 
and the light chains o f the antibody become separated.
6.10 Discussion
This chapter described the work that was carried out with MAbs raised against pORF6. 
The MAbs were tested in different assays that had pORF6 in different states i.e. in the 
western blot it is denatured whereas in the immune-precipitation it is in its native state. 
The immune-fluorescence assay also used pORF6 in its native state but inside an intact 
cell. The number of positive results was greatest with the western blot. As pORF6 
denatured in this assay, the epitopes recognised by the MAbs may have been more 
accessible.
It would be useful to use the MAbs that may be reacting to the N-terminal region of 
pORF6 in the DNA binding reactions. As mentioned previously, the C-terminal region 
of HSV-1 ICP8 does not affect the intrinsic binding ability of ICP8 to ssDNA, but the 
cooperative nature of binding. The ability of ICP8 to bind to DNA may be due to a 
region in the N-terminus, which may also be true for pORF6. Any of the MAbs which 
blocked DNA binding could be epitope mapped and this might provide some information 
on the nature and location of the DNA binding site.
The antibodies that could immune-precipitate ORF6 could also be used in a co-immune- 
precipitation assay to identify the proteins that pORF6 interacts with. ICP8 has been 
shown to bind to the origin binding protein of HSV-1. An interaction with the helicase- 
primase associated factor has also been demonstrated. The origin binding protein 
function of KSHV is speculated to be carried out by the K8 protein. If an interaction 
between pORF6 and K8 could be demonstrated, this would be further support for K8 in 
this role. An attempt was made to construct a baculovirus expressing K8 that could be
used for co-immune-precipitation assays. Unfortunately repeated attempts to clone K8 
were unsuccessful and this was left in order to concentrate on other work. It is also 
possible that certain MAbs might block a particular protein-protein interaction, and in 
this instance epitope mapping might provide information on the region of pORF6 
involved in the interaction.
The study of the formation of replication compartments in KSHV could also be carried 
out using the MAbs that have a positive reaction to pORF6 in immuno-fluoresence. 
KSHV positive cells that have been induced into lytic replication could be fixed and 
studied at a range of times and the progression of the replication compartment formation 
and maturation could be followed.
Chapter 7 
Discussion
7.1 General Discussion
The set of DNA replication proteins required for origin-dependent KSHV DNA 
replication includes six core replication fork proteins that are conserved amongst the 
herpesvirus family (Wu et a i, 2001). So far the KSHV core replication proteins have not 
been well characterised. The aim of this was project was to purify and characterise one of 
these core KSHV proteins, the ssDNA binding protein, pORF6. To date there has been 
no work published reporting the binding of pORF6 to ssDNA.
In this thesis the ability of pORF6 to bind to ssDNA was firstly established and then 
further investigated. This included determining the number of nucleotides required for 
pORF6 to bind to ssDNA, the effect of NaCl concentration on pORF6 binding, and 
establishing whether, like its homologue in HSV-1, ICP8, it binds to ssDNA in a 
cooperative manner (Ruyechan, 1983; Lee and Knipe, 1985; Dudas et al., 2001). This 
involved using two different DNA binding assays, EMSA and surface plasmon resonance 
(BIAcore).
The results demonstrated that pORF6 binds to ssDNA in both DNA binding assays. Like 
its homologue, ICP8, and other SSBs, pORF6 may bind cooperatively to ssDNA, as was 
demonstrated in both the EMSA and in the data generated from the BIAcore.
Cooperative binding would ensure that during viral DNA replication, KSHV ssDNA 
becomes covered by pORF6. This would not only aid the DNA polymerase by removing 
secondary structure but also protect the ssDNA from nuclease attack. As stated before 
this work should be repeated and extended to verify that pORF6 binds cooperatively to 
ssDNA.
The work carried out using the BIAcore also compared ICP8 and pORF6 binding to 
ssDNA, and demonstrated that each protein binds to ssDNA with a similar affinity. 
pORF6 associates with ssDNA at a slightly greater rate but is also dissociates from 
ssDNA slightly faster. The work using the BIAcore also compared pORF6 binding to 
ssDNA of 32 nt and 15 nt, and demonstrated a higher affinity for the 32 nt strand. This is 
probably because two molecules of pORF6 can bind cooperatively to the 32 nt DNA. 
However, this result could also be explained by 15 nt being too short for optimal binding 
of a single molecule of pORF6.
Previous publications have reported that the number of nucleotides required for ICP8 to 
bind to ssDNA lies within the range 12-40 nt (Ruyechan, 1983; O’Donnell et a l, 1987 
Gustafasson et a l , 1995; Bortner et a l , 1993; Makov et a l , 1996; Dudas and Ruyechan, 
1998.) These differences may depend in part on the experimental procedure used to 
determine this parameter. Also the occluded binding site (the length of DNA covered or 
rendered inaccessible when the protein is bound) and the interaction site (the length of 
DNA that directly interacts with the protein) may be different. The work for this thesis 
found that the minimal number of nucleotides required for pORF6 to bind to ssDNA in 
an EMSA was 14. However, an increase to 20 nt led to an increase in the level of 
pORF6 binding. It may be that 14 nt is not enough for the whole protein to bind to with 
20 nt allowing the whole protein to bind.
As previously mentioned, protein-DNA interactions are thought to be particularly 
sensitive to a change in NaCl concentration due to the cations interacting with the nucleic 
acid. A study on ICP8 investigated the effect of NaCl concentration on ICP8 binding to
ssDNA using a filter-binding assay (Ruyechan and Weir, 1984). Optimal binding was 
observed at 150mM NaCl and at 300mM NaCl the binding of ICP8 to ssDNA was 
dramatically reduced.
The effect of NaCl concentration on pORF6 binding to ssDNA was investigated by an 
EMSA in this study. Similar to HSV-1 ICP8, optimal binding occurred at 150mM NaCl. 
However, pORF6 was less sensitive to an increase in NaCl concentration than ICP8. This 
may be because of a dilution effect of loading the sarnies onto the gel. It would be 
informative to study the effect of NaCl on the binding of pORF6 and other SSBs, using 
the same method for each. This would establish whether any differences observed were 
because of real differences in the binding of these proteins to ssDNA or because different 
assays have been used. The results from the BIAcore indicated that although the pORF6 
and ICP8 bind to ssDNA with a similar affinity the kinetics of binding are not identical.
It is possible that this may be indicative of subtle differences between the functioning of 
the two proteins in infected cells e.g. the phase of viral DNA synthesis in KSHV infected 
cells is longer than during HSV-1 infection.
The panel of MAbs made against pORF6 were tested in immune assays using S f  cells 
infected with a recombinant baculovirus expressing pORF6, to establish which were 
positive for each assay. These were western blot, immune fluorescence and immune- 
precipitation assays. The results indicated that more MAbs may recognise linear than 
conformational epitopes as the western blot assay gave the most positive results.
Two of the MAbs that were positive in these assays were used in a western blot and 
immune fluorescence assays against KSHV infected B cells. The pORF6 expressed
during KSHV infection was detected by these antibodies demonstrating that reactivity is 
not confined to pORF6 over-expressed in S/bells. The immune fluorescence assay 
showed pORF6 to be in globular areas that may represent the replication compartments 
in which herpesviruses DNA synthesis is known to occur (Lukonis and Weller, 1996). It 
would be interesting to fix cells at several time points after induction and to monitor the 
development of the KSHV replication compartments with these antibodies.
Interactions of pORF6 with ssDNA and the other replication fork proteins could also be 
characterised using these MAbs. It would be useful to define the region of pORF6 
recognised by each MAb, by epitope mapping. The MAbs could then be used to 
determine the regions of pORF6 critical for its intrinsic binding to ssDNA, and also the 
region important for co-operative binding. Using these MAbs in co-immune 
precipitation assays with extracts from cells infected with KSHV could identify 
interactions between pORF6 and the other KSHV replication fork proteins or other 
KSHV proteins.
One potential interaction that could be tested for between pORF6 and the OBP of KSHV. 
The protein that is thought to play the role of OBP in KSHV is K8 (Lin et a l , 1999; 
AuCoin et a l , 2004). In HSV-1, ICP8 (SSB) and UL9 (OBP) have a functional 
interaction that stimulates the helicase activity of UL9 (Boehmer and Lehman, 1993). If 
K8 is the OBP of KSHV then it may also have a functional interaction with pORF6. If 
an interaction were to be established between these two proteins it would be more 
evidence that K8 plays the major role in origin recognition and the initiation of viral 
DNA synthesis.
The C-terminal region of ICP8 and also of adenovirus DBP is involved in cooperative 
binding of these proteins to ssDNA. Deletion mutants of ICP8 established that the C- 
terminal 60 residues are critical for cooperativity (Mapelli et a l , 2000). The crystal 
structure of this protein reveals that the C-terminal domain fits loosely into a concave 
surface on the back of the N-terminal domain (Mapelli et a l , 2004). The crystal 
structure of adenovirus DBP also reveals that it has a C-terminal ‘arm’ that hooks onto a 
second DBP monomer, which results in the formation of long protein chains along the ss­
DNA (Tucker, 1994). If pORF6 has a similar structure to ICP8 and DBP in that it has a 
C-terminal ‘arm’ that links onto the next molecule then a MAb binding to this region 
may abolish cooperativity. Deletions made in the C-terminus of pORF6 would provide 
more information on the mechanism of its cooperative binding.
The structure of ICP8 and pORF6
As mentioned previously the crystal structure of the homologous HSV protein, ICP8, has 
been solved. The protein consists of a large N-terminal region and a smaller C-terminal 
region (Mapelli et a l, 2005). The N-terminal region is described as consisting of head, 
neck and shoulder regions (see figure 1.7). The head region consists of eight helices, the 
front of the neck contains a five-stranded p-sheet and two helices (structurally similar to 
an OB-fold), the back of the neck has a three-stranded P-sheet and the shoulder contains 
an a-helical and p-sheet region. The C-terminal domain is entirely helical and is 
connected to the N-terminal domain by a disordered linker.
The neck region (530-1028) is proposed to be involved in DNA binding, since there are a 
number of aromatic and positively charged residues that are exposed. This is the same 
region of ICP8 that has been previously suggested for this function based on mutagenesis 
studies (Leinbach and Heath, 1989; White and Boehmer, 1999). The exposed residues
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Figure 7.1 An alignment of the SSBs from the human herpesviruses
The SSBs from the eight human herpesviruses were aligned using ClustalW and 
annotated using CHROMA. The virus from which the protein is from is indicated on 
the left hand side. Conserved amino acids involved in DNA binding in ICP8 (HSV-1) 
are highlighted with a red arrow. Conserved residues that form a hydrophobic patch 
on the N-terminus o f ICP8 are highlighted with a blue arrow. Conserved residues that 
are involved in zinc binding are indicated with a light green arrow. A FNF m otif 
conserved among the alpha herpesviruses is highlighted with a pink line below the 
alignment. The secondary structure o f ICP8 is shown above the alignment.
Horizontal cylinders indicate a-helices, horizontal arrows indicate (3-sheet. Elements 
are coloured dark pink for the head, blue and orange for the shoulder, light pink and 
grey for the neck, green for the zinc binding loop, mauve for the C-terminal helical 
domain. The dashed line indicates the region that was absent from the crystal 
structure. The number at the end o f each line indicates the residue number o f ICP8 at 
the end o f the line.The colour code for the amino acids is shown on the next page.
The colour code is as follows:
DE
ST
ILV
HKR
F H W Y
DEHKR
ACDGNPSTV
CDEHKNQRST
A C F G H IL M T V W Y
letter with a grey background indicates 
conserved residues
basic residues
Ser/thr
aliphatic
positive
aromatic
charged
small
polar
hydrophobic
that may be involved in DNA binding are Tyr543, Asn551, Arg772, Lys774, Arg776, Tyr988, 
Phe998 and Asn1002. Figure 7.1 shows an alignment of the SSBs from the eight human 
herpesviruses. The sequences were aligned using ClustalW and annotated using 
CHROMA (Goodstadt and Ponting, 2001), which colours conserved regions. The above 
mentioned residues are fairly well conserved within these herpesviruses and have been 
highlighted with a red arrow below the sequence. Arg772 is not conserved between ICP8 
and pORF6 but the replacement amino acid, lysine, also contains a basic side chain and 
would be able to contribute in the same electrostatic interactions with DNA as arginine. 
Also shown in the figure above the alignment is the secondary structure of ICP8 
determined by crystallography (Mapelli et a l, 2005). This secondary structure is likely to 
be largely conserved throughout human herpesvirus SSBs.
ICP8 is a zinc metalloprotein containing one zinc atom per molecule that as predicted is 
coordinated by three cysteines (Cys499, Cys502, Cys510). These amino acids are conserved 
in the human herpesviruses and have been highlighted with a light green arrow. Also 
conserved is Thr513, which further stabilizes the zinc loop in ICP8. These residues most 
likely have the same function in pORF6 as in ICP8.
The C-terminus of ICP8 has been shown to be important for cooperative binding. It is 
thought that it interacts with a hydrophobic patch in the head region of another molecule 
of ICP8 that is formed by Phe827, Phe843, Trp844, Leu857 and He865. These residues have
O'yn
been highlighted with a blue arrow in figure 7.1. The phenylalanine and the 
tryptophan are conserved within the human herpesviruses. Phe and Leu are not
0^ -1 Of'7
conserved but in pORF6 the replacements, Leu and Pro are also hydrophobic. lie 
is also not conserved and pORF6 is the only herpesvirus SSB in which the replacement 
amino acid does not have a similar side chain chemistry. The other proteins also contain
a hydrophobic residue at this point but pORF6 contains a cysteine. However, there is still 
a hydrophobic patch created by the other conserved amino acids that could interact with 
the C-terminus of an adjacent pORF6 molecule.
The extreme C-terminus of the human herpesvirus SSBs does not appear to have much 
sequence conservation. However, there is a FNF motif that is conserved within the alpha 
human herpesviruses that is thought to interact with the hydrophobic patch on the N- 
terminus of the next protein molecule. This is highlighted with a pink line underneath 
the alignment in figure 7.1. The other viral proteins shown in the alignment do not 
contain this motif but they do have two hydrophobic residues in the same region, which 
could also interact with the hydrophobic patch on the N-terminus of an adjacent protein 
molecule.
Figure 7.2 shows the secondary structure prediction of pORF6 generated using PSIPRED 
(Jones, 1999). Overall this is very similar to the actual structure of ICP8 for the 
corresponding regions of the alignment (figure 7.1). In ICP8, the region containing the 
amino acids involved in zinc binding has an a-helical structure (499-513 (figure 7.1-light 
green arrows)). The corresponding region containing the conserved residues in pORF6 is 
also predicted to be a-helical (455-470). The sequences containing the amino acids 
involved in DNA binding in ICP8 form a loop region (543-541) and two P-sheets (772- 
776 and 998-1002) (figure 7.1-red arrows). The first of these regions mainly consists of 
a loop structure in ICP8 but in pORF6 it is also predicted to contain a small a-helical 
structure (499-509). However, the two p-sheet regions in ICP8 have a calculated 
corresponding p-strand predictions in pORF6 (725-732 and 925-939). The hydrophobic 
patch in the head region of ICP8 that binds to the C-terminus of an adjacent molecule is 
a-helical with loop regions (827-865 (figure 7.1-blue arrows). The corresponding region
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1 0 1 0 1 0 2 0 1 0 3 0 1 0 4 0
HHHHCCHHHHHHHHHHHHHHHHHCCCCCCHHHHHHHHHHH
IYYLGPYAVLGDEVLSLLSTVGQAGVPWTAEGVASVIQDI
I I I I
1 0 5 0  1 0 6 0  1 0 7 0  1 0 8 0
P r e d : CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCC 
AA: ID D C E LQ FV G PE E PC L IQ G Q SW E E L FPSPG V PSL T V G K K
I I I I
1 0 9 0  1 1 0 0  1 1 1 0  1 1 2 0
Conf : baUaalilaXlllIlE
P red :
Pred: CCCCCCCCCCCC 
AA: RKIASLLSDLDL
1 1 3 0
Legend:
= h elix Conf: ]a a 2 11 E = confidence of prediction
> = > = strand
+
Pred: predicted secondary structure
= co il AA: target sequence
Figure 7.2 Secondary structure prediction of pORF6
The pORF6 amino acid sequence was analysed using the PSIPRED protein secondary 
structure prediction programme http://insulin.brunel.ac.uk/cgi-bin/psipred (Jones 
1999). The programme assigns an amino acid residue to a secondary structure m otif 
within the context o f the surrounding amino acids. The figure shows which amino 
acids are likely to form a-helices, (3-sheets or non-specific coiled loops.
in pORF6 is also predicted to be a-helical with loop areas (772-792). In addition, the C- 
terminus of ICP8 is a-helical, which is also the predicted structure of the C-terminus of 
pORF6.
The regions of pORF6 discussed above that contain the conserved important functional 
residues have the same secondary structure as ICP8 consistent with them functioning in 
the same manner in the binding with ssDNA. Similarly, the cooperative nature of 
pORF6 binding with ssDNA may like ICP8, be due to a C-terminal ‘arm’ linking onto 
the next molecule and consistent with this, the predicted structure in this region of 
pORF6 is very similar to the ICP8 structure. The information gained from the alignment 
and secondary structure prediction provides a greater understanding of how pORF6 may 
be binding to ssDNA. In addition, knowledge of the structure of ICP8 and the 
identification of residues involved in important functions of the protein provides 
information that could be used to design mutations in pORF6 to further characterise its 
binding to ssDNA.
Investigating the DNA replication proteins of the herpesviruses not only provides 
additional information on how these viruses replicate, but also characterises a potential 
target for anti-viral therapy. The disruption of protein-protein interactions between the 
DNA replication proteins of the herpesviruses represents a novel anti-viral strategy. The 
interaction between the HSV-1 DNA polymerase (UL30) and its processivity factor 
(UL42) can be disrupted by short peptides corresponding to the C-terminus of UL30 
(Marsden et al., 1994; Digard et al., 1995; Bridges et al., 2000), which inhibits the ability 
of UL30 to synthesise long DNA chains. Loregian et al. (1999) demonstrated that a 
peptide corresponding to the C-terminal 27 residues of UL30 fused to the B subunit of
E.coli enterotoxin can enter the nucleus of HSV-1 infected Vero cells and inhibit viral 
replication. A peptide corresponding to the C-terminus of the HCMV DNA polymerase 
also blocks the interaction between the HCMV polymerase and its accessory factor and 
specifically inhibited the stimulation of the polymerase by the accessory factor (Loregian 
et a l , 2003). However, using a peptide as an anti-viral drug imposes the potential 
problem of an immune response from the host. More recently small molecules that also 
inhibit the interaction between UL30 and UL42 have been identified (Pilger et al., 2004). 
One of these molecules had more potent anti-viral than cytotoxic activity. Molecules of 
this type may have better potential as anti-viral drugs than peptides as they are less likely 
to cause an immune response.
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